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Q U IL L ON SC A LPEL
provides

a medium

through

9

This section

which

Canadian

surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs of surgery.

BASIC SURGICAL EXAMINATION*
In his paper in this issue of the Journal
(page 59) Couture has pointed out that both
the American College of Surgeons and the
Royal Collfege of Physicians and Surgeons
of Canada have agreed that a 2-year pro
gram in basic surgery knowledge, com
mon to all surgical disciplines, is needed;
the program directors have been left to
define the specific objectives. Couture em
phasizes that if basic scientists are intimately
involved with the planning and implementa
tion, such integration would also benefit
the primary medical school program. At
present in most medical schools there ap
pears to be a great gap between the teach
ing of the basic sciences in the first 2 years
and the clinical applications in the final
2 years. This sharp division makes difficult
the teaching of basic sciences in postgraduate
surgical programs.
In 1970 the Committee on Examinations
of the Royal College of Physicians and Sur
geons of Canada began to investigate the
possibilities of a mid-training examination as
a step in the certification process in all
surgical specialties. It was proposed that if
all medical school information is considered
basic to all physicians, there must be an
other level of information basic to all sur
geons, regardless of specialty.
The Committee on Examinations pro
posed the creation of a basic principles
examination in medicine, pathology and
surgery, and, in 1973, the Principles of
Surgery Examination Committee was created
to explore the possibility of such an exami
nation. The committee, composed of eight
members, included one member nominated
by each of the surgical specialty committees.
Available as a resource for this examination
*Presented at the meeting of the Canadian Asso
ciation of Clinical Surgeons, Quebec City, PQ,
Mar. 18, 1975.

were approximately 7000 items in the
McLaughlin Test Centre.
At its first meeting, the Principles of
Surgery Examination Committee drafted an
outline of the knowledge expected of each
surgical trainee — knowledge that seemed
fundamental to all surgical specialties. In
accordance with this outline 1500 multiplechoice questions were obtained from the
McLaughlin Test Centre, chiefly general
surge^j^orthopedic and urology questions
with some medicine, pathology, ophthal
mology and psychiatry included. At its
second meeting, the committee selected 240
items to create an examination that met the
basic specifications; this number was later
reduced to 233 items, categorized as follows:
1. Vital functions
Shock
Resuscitation (cardiac arrest, pulmo
nary failure, renal failure)
Postoperative care and complications
— pulmonary, cardiovascular, gas
trointestinal, neurologic and fluidelectrolyte (e.g., atelectasis, cardiac
failure, ileus, hepatitis, oliguria, hy
potension)
Thermal injury — cold injury.
2. Body response to trauma
Surgical endocrinology — interrela
tions of hormones in homeostasis
Surgical metabolism — basic require
ments, dosage, nutrition and starva
tion, hyperalimentation
Acid-base balance
Specific problems of trauma — cranio
facial, chest, abdomen, extremities.
3. Infections and neoplasia
Specific infections
Local and systemic infections
Antibiotics in clinical use
Epidemiology of infections and cancer
Radiation and radiation responses
Oncology and neoplasia generally.
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4. Bleeding, coagulation, thrombosis and
surgical immunology
Coagulation and clotting abnormalities
Transfusion, blood, blood products
Typing — blood and tissue compati
bility, histology, hematology
Rejection and autoimmune patterns
Immunosuppression.
5. Clinical pharmacology
Diuretics
Synthetic hormones
Anticancer drugs
Anesthetic agents
Narcotics, sedatives and other mood
changing drugs
Cardiac, autonomic and antihyperten
sive drugs.
6. Miscellaneous
Statistics and probability
Genetics
Embryology
Surgical history
Anatomy
Clinical psychology
Chemical toxins — pollution.
In June 1974, this examination was first
administered, without fee, to 461 candidates
(general surgery, 189; cardiovascular and
thoracic surgery, 9; neurosurgery, 25; or
thopedics, 118; otolaryngology, 41; urology,
60; and plastic surgery, 19). The only pre
requisites were registration in a Canadian
training program for at least 18 months and
a defined area of specialty interest. The
results were a surprise: of the 233 items,
the average number of answers correct was
only 131. Techniques of multiple-choice
examination permit a 20% chance of correct
answers merely by guessing, giving every
candidate 48 correct answers, so the average
candidate was credited with only 83 correct
answers based on actual knowledge.
After the results of the examination were
known, interest arose to develop a “cutting”
score and to define satisfactory or unsatis
factory performance. An attempt was made
to score this basic examination by use of a
reference point derived from candidates’
performance on final written certification
examinations. By transposition of the results
from the final written examination to the
basic text of 233 items it was possible to
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set the passing score at 151 items correct,
which put the pass rate in the basic exami
nation at 15% and the fail rate at 85% —
an unacceptable result.
With another method, Canadian candi
dates were selected as a reference group and
were automatically passed at 83% (one
standard deviation). All others were scored
against this reference group. This automatic
ally regulated the pass rate and related it
to one subgroup of candidates taking the
examination, but did not alter the fact that
in order to pass a candidate needed only
119 correct answers —• 48 obtainable by
chance alone and only 72 by actual knowl
edge. As expected, there were differences
among the specialties, and, in accordance
with previous experience, the poorest results
came from candidates educated outside
North America.
The overall performance may be attri
buted to one or more of several factors:
1. The questions, although appropriate
in the final certifying process, may not be
appropriate to the basic level.
2. Residents are much more knowledge
able on the basic elements at the completion
of their program than at the mid-point.
3. These basic elements are not covered
in any of the residency programs and the
quantity of basic questions in the final
examination is so small that it does not
greatly affect the result of the score.
4. Knowing the examination would not
count, the candidates put little effort into it.
5. The group was polluted by a large
number of candidates who might not com
plete their training.
6. Other factors not obvious at the
time.
After the initial experience, this examina
tion was given for a second time in 1975
to another group of residents in training;
the results were not significantly different,
though some of the interspecialty differences
became less prominent.
A third version of the basic surgical
examination, created according to the ini
tial specifications, was given in September
1976. Formal registration, review of creden
tials and payment of a fee will now be
instituted for all examinees. The 1976
examination is a required examination in
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some specialties and optional in others.
The evaluation system must somehow pa
rallel the education system and this exami
nation is an attempt to accomplish such a
purpose.
C. B. M u e l l e r , MD, FRCS[C]
TOXIC MEGACOLON
In this issue of the Journal (page 36) Patel
and Stone report their experience in the sur
gical management of patients with toxic
megacolon at the Toronto General Hospital
over a 16-year period. The article is note
worthy in that the mortality rate for total
and subtotal colectomy (mostly the latter)
was only 5% . This is the lowest mortality
rate for colectomy reported in a large series
of patients with toxic megacolon and com
pares favourably with the 4.8% mortality
reported by Turnbull, Hawk and Weakley1
with the ileostomy-colostomy technique
followed by interval colectomy. The inci
dence of toxic megacolon in patients with
granulomatous and ulcerative colitis was
5.7% in the series reported by Patel and
Stone and 6.3% in the series reported by
Turnbull, so one may conclude that the
diagnostic criteria for patient selection were
similar in the two groups of patients.
Turnbull has used the “blow-hole” pro
cedure in the management of toxic mega
colon because of sealed colonic perforations
that leak during mobilization of the colon,
even with the most meticulous surgical tech
nique. The resulting fecal peritonitis causes
death and illness in such patients.- Fecal
spillage at operation was not avoided in the
patients reported by Patel and Stone, since
10 of 40 patients undergoing colectomy had
recognized spillage at operation, although
in two patients the spillage had occurred
before operation. What is important is that
the consequences of such spillage were suc
cessfully managed, resulting in a low morta
lity.
Readers should, however, not extrapolate
the enviable results of colectomy reported
by Patel and Stone to their own situation.
The Toronto General Hospital is well
equipped, with the supporting staff and
facilities that make for effective manage
ment of infections and intensive care. A
surgeon working in a community hospital
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on his own may not be able to cope with
all the problems created by fecal spillage
in the peritoneal cavity. Thus, local condi
tions and resources may dictate that
ileostomy-colostomy is still the preferred
procedure in the management of patients
with toxic megacolon.
Despite the enormous respect of the sur
gical community in North America for
Turnbull, his ileostomy-colostomy procedure
for toxic megacolon does not seem to have
been widely accepted.3 This may be because
surgeons have failed to appreciate the likeli
hood of operative fecal spillage occurring
in patients with toxic megacolon, as pointed
out by Turnbull, but also because anaerobic
gram-negative sepsis can be controlled ef
fectively. Thus, many surgeons believe that
limited fecal spillage is not a catastrophe
and that results comparable to those reported
by Stone and Patel can be achieved with
colectomy.4
0 . G. T h u r s t o n , MD, FRCS[C]
Department of surgery,
University of Alberta Hospital,
Edmonton, Alta.
R eferences
1. T urnbull RB, Hawk WA, W eakley FL:
Surgical treatment of toxic megacolon.
Ileostomy and colostomy to prepare pa
tients for colectomy. Am J Surg 122: 325,
1971
2. Koudahl G, K ristensen M: Toxic megacolon
in ulcerative colitis. Scand J Gastroenterol
19: 417, 1975
3. F ry PD, A tkinson KG: Current surgical ap
proach to toxic megacolon. Surg Gynecol
Obstet 143: 26, 1976
4. M ungas JE, M oossa AR, Block GE: Treat
ment of toxic megacolon. Surg Clin North
Am 56: 95, 1976

AORTIC ANEURYSMS
AND ANGIOGRAPHY
The role of routine angiography in the man
agement of asymptomatic abdominal aneur
ysms remains controversial. Some1' 4 have
advocated its use, but some vascular sur
geons consider it unnecessary and others5' 7
regard it as unsafe for routine study of
such patients. Cyr and colleagues in this
issue of the Journal (page 57) consider this
controversy in the light of their experience
with angiography. The mortality for elective
resection of aneurysms is less than 7%
compared with a mortality of 45% for re
section of ruptured aneurysms. Patients who
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have undergone elective resection have a
5-year survival of 60 to 6 5 % .8' 10 Late
deaths are related primarily to other mani
festations of atherosclerosis. The major
causes of death are myocardial infarction
(in 40% ), cancer (23%) and stroke (2% ).8
In considering angiography as a routine
diagnostic aid in asymptomatic abdominal
aortic aneurysms one should also take into
account the information that can be ob
tained from routine clinical examination and
noninvasive investigation. Cyr and col
leagues state that in 8 of 37 patients not
operated upon the operation was deferred
because of the angiographic findings; the
problems were poor run-off, multilevel
atheromatous disease and polyaneurysmal
disease. The poor run-off would have been
revealed by diminution in the peripheral
pulses on clinical examination; the presence
of an extension of the aneurysm above the
renal vessels would have been suggested by
a physical examination when it was not pos
sible to get between the aneurysm and the
xiphoid process; polyaneurysmal disease
may have been suggested by physical exam
ination, and routine chest radiography might
have demonstrated dilatation of the thoracic
and upper abdominal aorta. With respect to
renal artery surgery, 9 of 46 patients re
quired some form of renal revascularization.
The 20% incidence of renal artery stenosis
is similar to that found in other reports;
however, only 50% of these were consid
ered hemodynamically significant according
to the usual criteria.11 (Cyr and colleagues
do not indicate how many of these patients
were hypertensive.)
There are several definite indications
for preoperative angiography in patients
with clinically suspected aneurysms of the
abdominal aorta: the presence of a noncalcified abdominal mass not confirmed by
ultrasound, indicating the likelihood of a
nonaneurysmal mass with transmitted pulsa
tions; an aneurysm extending to the xiphoid
process on physical examination or a
widened thoracic aorta on routine chest film,
suggesting extension into the suprarenal
aorta or a thoracic abdominal aneurysm;
hypertension, indicating associated renovas
cular disease; and symptoms suggesting in
testinal ischemia or the finding of a high-
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pitched bruit predisposing to postoperative
colonic ischemia or intestinal angina. In ad
dition, because of the occurrence of cases
of clinically detectable, coexistent, aortoiliac, femoropopliteal disease or polyaneur
ysmal disease angiographic information is
essential in planning distal reconstruction
after resection of an aneurysm.
G. E vans, MB, FRCS
Department of surgery,
McMaster University Medical Centre,
Hamilton, Ont.
R eferences

1. K ahn PC, C allow AD: Catheter arterio
graphy in evaluation of abdominal aortic
aneurysm. Am J Roentgenol Radium Ther
Nucl Med 98: 879, 1966
2. R obicsek F, D augherty H K , M ullen DC,

et al: Value of angiography in diagnosis
of unruptured aneurysms of abdominal
aorta. Ann Thorac Surg 11: 538, 1971
3. J ohnson WC, N abseth DC: Visceral infarc
tion following aortic surgery. Ann Surg
180: 312, 1974
4. F oster JH: Arteriography: cornerstone of
vascular surgery. Arch Surg 109: 605, 1974
5. D anielson GK, P ayne WS: Arteriography
and abdominal aortic aneurysm (C). JAMA
209: 1366, 1969
6. O chsner A j r , D ecamp PT: Management
of abdominal aortoiliac aneurysms asso
ciated with occlusive arterial disease: study
of 31 operative cases. South Med J 53:
732, 1960
7. R ob CG, W illiams JP: Diagnosis of aneur
ysms of abdominal aorta (analysis of 100
patients). J Cardiovasc Surg 2: 55, 1961
8. H icks GL, E astland MW, D eW eese JA, et
al: Survival improvement following aortic
aneurysm resection. Ann Surg 181: 863,
1975
9. D eB akey ME, C rawford ES, C ooley DA,
et al: Aneurysm of abdominal aorta: anal
ysis of results of graft replacement therapy
one to eleven years after operation. Ann
Surg 160: 622, 1964
10. Szilagyi DE, S m ith RF, D e R usso FJ, et al:
Contribution of abdominal aortic aneurys
mectomy to prolongation of life. Ann Surg
164: 678, 1966
11. Brewster DC, R etana A, W altman A, et
al: Angiography in management of aneur
ysms of abdominal aorta. Its value and
safety. N Engl J Med 292: 822, 1975
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1976 DAVIS & GECK SURGICAL ESSAY
THE DELAYED HYPERSENSITIVITY RESPONSE:
CLINICAL APPLICATION IN SURGERY*
JOHN B. PIETSCH, M D t and JONATHAN L. ME A KINS, MD, FRCS[C]
The detection of anergy or relative anergy by
delayed hypersensitivity skin tests was pre
dictive of infection and related mortality in 354
surgical patients. Cancer or advanced age alone
did not account for the increased morbidity and
mortality seen in this study. Altered delayed
hypersensitivity response is a reflection of
abnormalities in cell-mediated immunity and
possibly humoral or phagocytic defects, or both.
Skin testing is of value to the clinical surgeon
both in identifying the population at risk and in
monitoring the immune response to therapy in
the seriously ill patient. Failure to improve skintest response may indicate underlying infection
or malnutrition, which, if untreated, results in
a high mortality.
La detection des etats d'anergie ou d’anergie
relative, au moyen d’une cuti-reaction d’hypersensibilite retardee, a permis de predire I'infection et la mortalite associee, chez 354 patients
de chirurgie. Le cancer ou I'age avance seuls
n'expliquent pas la morbidity e t la mortalite
accrues observees au cours de cette etude. Une
reaction d'hypersensibilite retardee modifiee est
I'expression d'anomalies de I’immunite cellulaire
et, possiblement, de I'immunite humorale ou
phagocytaire, ou des deux. La cuti-reaction est
d’interet pour le chirurgien et lui permet d'identifier la population menacee et de surveiller
I'effet du traitement sur la reponse immunitaire
chez les patients gravement malades. L'impossibilite d'ameliorer le resultat de la cuti-reaction
peut indiquer la presence d'une infection sousjacente ou d’un etat de malnutrition, qui, lorsque
laisses sans traitement, entrainent un taux de
mortalite eleve.

I t is well known that certain surgical pa
tients have a “susceptibility” to infectious
complications and that, after the onset of

*From the departments of surgery, Royal Victoria
Hospital and McGill University, Montreal, PQ
H3A 1A1.
Supported by a grant from the Medical Research
Council of Canada.
tWinner of the
Essay Award.

1976 Davis & Geek Surgical

Reprint requests to: Dr. J. B. Pietsch, Department
of surgery, Royal Victoria Hospital, 687 Pine
Ave. W, Montreal, PQ H 3A 1A1.

infection, they do poorly despite aggressive
supportive efforts. This is attributed to ab
normalities in host defence;1 and indeed
delayed hypersensitivity (DH) skin testing
in surgical patients to assess immune com
petence has shown that patients who are
at high risk for septic complications and
death have depressed or absent responses
to a battery of five recall antigens.2
The relation between host-defence mech
anisms and infectious complications follow
ing surgery was studied in 354 surgical
patients who had DH skin testing and whose
clinical courses were examined.
H is t o r ic a l R e v ie w

The DH response classically refers to the
cutaneous reaction of erythema and indura
tion occurring 24 to 48 hours after intradermal injection of a foreign antigen to
which an individual has been previously
exposed. One of the first scientific observa
tions of this response was made by Jenner3
in 1798: the injection of vaccinia virus into
an individual who previously had been im
munized against vaccinia was followed by
the appearance of vesicles and erythema
at the injection site, reaching a peak at 24
to 72 hours. In 1890, Koch4 injected live
tubercle bacilli intradermally into guinea
pigs previously infected with tubercle ba
cilli and observed erythema and induration
at the injection site at 24 hours, which pro
gressed to local tissue necrosis; in contrast,
he did not observe this response in un
infected animals. The former reaction was
not dependent on the use of live bacilli,
for either killed bacilli or extracts of the
bacillus could elicit the same response.
These findings provided the basis for the
old tuberculin and purified protein derivative
(PPD) skin tests of Mantoux that are the
model for the D H response.
The distinction between the tuberculintype reaction and the immediate hypersensi
tivity response (e.g., the Arthus reaction) was
made by Zinsser and Mueller5 in 1925.
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They discovered that the DH response did
not require the presence of antibody as did
the immediate response. Later, Landsteiner
and Chase0 reported that it was possible to
transfer delayed skin reactivity to picryl
chloride in guinea pigs with peritoneal leu
kocytes from sensitized animals, and Chase7
discovered that response to PPD could also
be transferred by leukocytes. The DH re
sponse was therefore “cell mediated” and
could not be transferred by serum, a char
acteristic of the immediate “humoral-mediated” reactions.
The leukocyte involved in the DH re
sponse is the T (thymus-dependent) lympho
cyte. Not only lymphocytes but lymphocyte
extracts (transfer factor) can transfer cu
taneous reactivity in man.8 Furthermore,
RNA extracted from sensitized lymphocytes,
which differs from transfer factor, has also
been shown to transfer cell-mediated im
munity.9
The basis for the DH response is the
ability of the body, in particular the T
lymphocyte, to recognize an antigen (e.g.,
virus, bacteria or protein) as foreign. Entry
of a foreign antigen into the body of an
immunocompetent individual initiates a
series of events that are independent of the
nature of the antigen. Locally, the antigen
combines with tissue proteins and cellular
elements to produce a vasoactive factor.
This permits the escape of neutrophils,
lymphocytes and monocytes as well as
plasma proteins from the local vessels, with
subsequent migration to the area of the
antigen. Opsonization of the antigen and
phagocytosis by macrophages follow. In the
regional lymph nodes, the development of
pyroninophilic cells or immunoblasts occurs
in the mid- and deep cortex. These cells
proliferate over 4 to 5 days, then divide
to form small lymphocytes sensitized to the
antigen and are then released into the sys
temic circulation.
If, later, there is contact with the same
antigen, a different response occurs. The
antigen is “recognized” by a few of the
circulating sensitized lymphocytes that, on
contact, release various chemical mediators
or lymphokines such as neutrophil and mo
nocyte chemotactic factors, blastogenic fac
tor and migration inhibition factor. These
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lymphokines cause many nonsensitized cells
(primarily lymphocytes and monocytes) to
migrate to the area and to dispose of the
antigen and cellular debris. It is this influx
of cells and plasma proteins over 24 to 48
hours that causes the induration of the posi
tive response to a DH skin test. An inter
ruption of this chain of events could alter
the final response. A negative skin-test re
sponse (anergy) can result from either fail
ure of prior exposure to the antigen or a
variety of congenital or acquired deficien
cies, which include serum inhibitors and
leukocyte abnormalities. Such cellular de
fects could result in decreased resistance to
infection in the surgical patient.
Measurements of the DH response have
aided the evaluation of previous exposure to
many diseases. These infections may be
fungal (candidiasis, trichophytosis, histo
plasmosis, coccidiomycosis), viral (mumps),
protozoal (leishmaniasis, echinococcosis) or
bacterial (tuberculosis, leprosy). In each
case the mechanism is the response of pre
viously sensitized lymphocytes to the recall
antigen. The frequent exposure to some of
these diseases increases the probability that
an individual will respond to several among
a group of skin tests using recall antigens.
In hospitalized patients the use of five recall
antigens (PPD, mumps, candidin, trichophytin, streptokinase—streptodomase) will
result in a positive response to two or more
antigens in approximately 90% of patients
tested.s- 9 Similar studies with recall anti
gens have been used to assess the immune
competence of patients.10 13
Other skin-test agents have been used.
Chemicals such as dinitrochlorobenzene
(DNCB) and dinitrofluorobenzene (DNFB)
test the immune system somewhat differ
ently. DNCB, a hapten, is absorbed from
the skin surface and a small proportion is
bound to tissue protein. This haptenprotein moiety then acts as an antigen and
the process of local antigen recognition, cel
lular infiltration and production of sensitized
small lymphocytes in the regional lymph
node occurs. After 7 to 21 days the sensi
tized circulating lymphocytes will react
either with the remaining antigen in the
skin or with a challenge dose of DNCB,14
producing a positive cutaneous response.
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sessing the competence of the entire DH
The DNCB test has the advantage of assequence and of not relying on previous
antigen exposure. However, because of the
time factors involved, it is difficult to use
frequently on the same patient.
P atients

and

M ethods

Patients
The study group comprised 354 patients
treated in the surgical wards and the in
tensive care unit of the Royal Victoria
Hospital, Montreal from July 1, 1975 to
June 30, 1976. All available and willing
patients were tested with the exception of
those who were admitted for minor low-risk
procedures (e.g., hernia repair and hemor
rhoidectomy). Their admitting diagnoses are
summarized in Table I; 286 (80.8%) of
these patients underwent a major surgical
procedure, and the remainder had either in
operable cancer or acute illness that resolved
with conservative management. Their ages
ranged from 18 to 92 years (mean, 56 yr);
70.6% were aged 50 years or older.
Skin Testing
Five recall antigens were used: PPD (1
TU/0.1 ml, Connaught Laboratories, Willowdale, Ont.); mumps skin-test antigen
(undiluted, Eli Lilly Company, Indianapolis,
IN); and candidin, trichophytin, and strepto
kinase—streptodornase (Varidase) (1000
U/ml, Hollister-Stier Laboratories, Missis
sauga, Ont.). A control solution consisted
of buffered diluent (undiluted, Hollister-Stier
Laboratories). Syringes were prepared with
0.1 ml of each solution just before intradermal injection.
All tests were administered by one person,
and the diameter of induration (mm) at 24
and 48 hours after injection was measured
and recorded by the same observer. A skin
test was considered positive if the indura
tion at either reading was 5 mm or greater.
The patients were classified according to
their response to each of the five recall anti
gens — normal (two or more positive), rela
tive anergy (one positive) or anergy (no
positive responses). If there was a response
to the control solution, the diameter of
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TABLE I.—D iagnosis

Diagnosis

No. of patients
(and. % )

Neoplastic disease.....................
Colon...................................
Metastatic..........................
Other...................................
Biliary tract disease.................
Acid-peptic ulcer.......................
Sepsis...........................................
Gastrointestinal bleeding.........
Trauma.......................................
Obesity (for bypass)................
Small-bowel obstruction..........
Pancreatitis................................
Inflammatory bowel disease...
Other...........................................

103 ( 29.1)
44 (12.4)
33 ( 9.3)
26 ( 7.4)
76 (21.5)
37 (10.5)
18 (5.1)
18 (5.1)
16 ( 4.5)
11 (3.1)
10 ( 2.8)
9 (2.5)
6 ( 1.7)
50 (14.1)

Total...................................

354 (100.0)

induration was subtracted from that of each
of the other five readings.
Of the 286 patients operated on 218
(76.2%) were tested preoperatively; 97 were
retested postoperatively. Sequential testing
(more than one test) was done on 178
(50.3%) of the 354 patients. Patients were
assessed with respect to sepsis and mortality.
Sepsis was defined as the presence of posi
tive blood cultures or abscess documented
either at operation or autopsy.
Statistical analysis was performed using
the chi-square test.
R esults
The 354 patients were divided according
to the timing of skin testing into three
groups: 218 tested preoperatively (group 1),
75 tested after major trauma or surgery
or both (group 2), and 61 tested but not
operated upon (group 3) (Table II). Among
the group 1 patients 26 (11.9% ) had altered
cutaneous responses and there was a signifi
cantly higher rate of sepsis (P < 0.025)
and death (P < 0.001) than among normal
responders. Similarly, of the 75 patients in
group 2, 64 (85.3%) were anergic or rela
tively anergic with an associated high rate
of sepsis (P < 0.001) and mortality (P <
0.001). Among the patients in group 3 the
incidence of sepsis and death was statis
tically different (P < 0.001) for the 20
(32.8%) abnormal responders compared
with the normal responders.
Of the 178 patients tested sequentially,
97 were tested before and after operation
(Table III). The 83 patients with either an

18

THE CANADIAN JOURNAL OF SURGERY

Vol. 20

TA B LE II.—M orbidity and M ortality (I nitial Sk in T est )

No. of patients
(and %)

Group and response

Sepsis (and %)

Deaths (and %)

1
N *............................................................
R A .................................... ......................
A ..............................................................

192 (88.1)
14 ( 6.4)
12 ( 5.5)

8 ( 4.2)
3 (21.4)
2 (16.7)

6 ( 3.1)
5 (35.7)
4 (33.3)

N ....................................... ....................
R A .................................... ....................
A ........................................ ....................

11 (14.7)
16 (21.3)
48 (64.0)

1 ( 9.1)
11 (68.7)
34 (70.8)

0(0)
3 (18.7)
15 (31.2)

N ....................................... ......................
R A .................................... ....................
A ........................................ ....................

41 (67.2)
4 ( 6.6)
16 (26.2)

0( 0)
1 (25.0)
4 (25.0)

0(0)
1 (25.0)
7 (43.7)

2

3

*N = normal, RA = relative anergy, A = anergy.
TABLE III.— P reoperative
Preoperative

Postoperative

and

No.
of patients

P ostoperative T ests

Septic
complications

Deaths

N
N
N

N ............................... . .71
R A .............................. . 0
A ............................... .. 3

0
0
3

0
0
3

RA
RA
RA

N .............................. .. 6
R A .............................. . 3
A ................................. 3

0
2
1

0
2
3

A
A
A

N ............................... .. 4
R A ............................. .. 2
A ............................... .. 5

0
0
2

0
0
3

97

8

11

T otal

im p r o v e m e n t in s k in -te s t re s p o n s e p o s to p e ra tiv e ly o r c o n tin u a tio n o f a n o r m a l r e s p o n s e
h a d n o a s s o c ia te d in fe c tio u s c o m p lic a tio n s
o r m o r ta lity . H o w e v e r, in f o u r o f th e e ig h t
p a tie n ts w h o w ere a n e r g ic o r re la tiv e ly
a n e r g ic p r e o p e ra tiv e ly a n d h a d n o d iffe re n t
r e s p o n s e s a f te r o p e r a tio n , se p sis d e v e lo p e d ,
a n d fiv e o f th e m d ie d . L ik e w is e o f th e six

p a tie n ts w h o s e re s p o n s e s w o rs e n e d p o s to p e ra tiv e ly , f o u r h a d s e p tic c o m p lic a tio n s
a n d all six d ie d .
T h e in c lu s io n o f th e o th e r 81 s e q u e n tia lly
te ste d p a tie n ts (firs t te s te d a fte r m a jo r
tr a u m a o r s u rg e ry o r b o th a n d th o s e n o t
o p e r a te d o n ) d id n o t a lte r th e se re su lts
(T a b le IV ) . T h ir ty p a tie n ts w ith a n e rg ic

TA B L E IV.— I mmunologic R esponse : S equential T esting

First
tests

Subsequent
tests

No. of
patients

Sepsis (and %)

Deaths (and %)

N
N
N

N ............................... . .76
R A ............................. . 0
A ............................... .. 3

5 ( 6.6)
0 ( 0 )
3 (100.0)

0( 0 )
0( 0 )
3 (100.0)

RA
RA
RA

N .............................. ..21
R A ............................ .. 3
A ............................... .. 7

8 ( 38.1)
2 ( 66.7)
4 ( 57.1)

0( 0 )
2 ( 66.7)
7 (100.0)

A
A
A

N .............................. .3 0
R A ............................. . 8
A ................................. . 30

14 ( 46.7)
3 ( 37.5)
19 ( 63.3)

2 ( 6.7)
1 ( 12.5)
20 ( 66.7)

58

35

T otal

178
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TABLE V.—E ffect of M alignant D isease

►

y
t

*

Sepsis (and %)

Deaths (and %)

Cancer
N .............................................
R A ...........................................
A ..............................................

62 (60.2)
12(11.6)
29 (28.2)

4 ( 6.4)
2(16.7)
14 (48.3)

4 ( 6.4)
6(50.0)
11 (37.9)

No cancer
N ..............................................
R A ..........................................
A ..............................................

182 (72.5)
22(8.8)
47 (18.7)

5 ( 2.7)
11 '50.0)
25 (53.2)

2 ( 1.1)
3(13.6)
15 (31.9)

responses maintained an anergic response;
sepsis developed in 63.3%, with an overall
mortality of 66.7% . The mortality, how
ever, was only 7.8% in those 38 patients
with a prior anergic response whose skin-test
responses improved, despite a 44.7% rate
of sepsis. Similarly, a high rate of sepsis
(60%) and death (90%) occurred in the
10 patients whose responses initially were
relatively anergic and whose responses did
not improve. There were no deaths among
the patients with relatively anergic responses
whose responses later became normal. All
three patients with conversion from normal
to anergic response manifested sepsis and
died whereas no deaths occurred in the 76
normal responders who remained normal.
Cancer was present in 103 (29.1%) of
the 354 patients. There was a significant
difference (P < 0.25) in the proportion with
anergy and relative anergy in this group
(39.8%) and in those who did not have
cancer (27.5%) (Table V). The presence
of cancer did not, however, alter the in
cidence of sepsis or the mortality in any of
the three skin-test response groups (anergy,
relative anergy, normal).
The effect of age on skin-test response,
incidence of sepsis and mortality is seen in
Table VI. In patients under 30 years of age,
trauma contributed to the increased propor
tion with altered responses (35.1%). Se

quential studies indicated that in this group
reversion to normal followed appropriate
therapy. There is a gradual increase in the
rate of anergy and relative anergy from
20% in the 4th decade to 33.9% in the
8th decade. Above 80 years of age, 62.5%
of patients have altered skin-test responses
with a 40.6% incidence of sepsis and a
mortality of 37.5% . The increase in mor
bidity and mortality is proportional to the
increase in anergy and relative anergy.
D iscussion
The distribution of cutaneous responses
(anergy, relative anergy and normal) to ubi
quitous recall antigens used in the 218 pa
tients in group 1 was similar to that reported
by Palmer and Reed,10 and reflects a typical
hospitalized population. There was an in
creased rate of septic complications (P <
0.25) and mortality (P < 0.001) in the
group with altered preoperative cutaneous
responses.
Sequential measurements of DH response
reflect accurately the evolution of the pa
tients’ clinical course. Among patients with
normal responses before operation whose
responses remained normal after operation
and among those whose abnormal responses
subsequently became less so there were no
deaths. However, among those whose re
sponses remained abnormal and among

TABLE VI.—E ffect

Age (yr)
30
40
50
60
70
-

on I mmunologic R esponse

No. of patients
(and %)

Condition

19

30
—
—
—
—
—
80

39
49
59
69
79

No.
of patients

A /R A , %

37
25
42
75
87
56
32

35.1
20.0
21.4
24.0
31.0
33.9
62.5

of

Age
Sepsis (and %)
5
3
7
11
14
9
13

(13.5)
(12.0)
(16.7)
(14.7)
(16.1)
(16.1)
(40.6)

Deaths (and %)
1
0
2
10
10
7
12

( 2.7)
( 0 )
( 4.8)
(13.3)
(11.5)
(12.5)
(37.5)
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those whose tests showed they were less
responsive the mortality was 78.6% . The
results of skin testing before and after oper
ation in 52 patients indicated that uncom
plicated surgery does not alter skin-test
response13 in contrast to the report of
Slade and associates.16 Postoperative alter
ation in skin-test response, therefore,
accurately indicates abnormalities in cellmediated immunity.
In the patients in group 2 prior skin
testing often was not feasible. Many were
tested in the surgical intensive care unit
following emergency operation. In these a
high incidence of septic complications
(70% ) was associated with anergy or rela
tive anergy. However, response to appro
priate therapy, including restoration of
adequate blood volume, nutritional support
and aggressive treatment of infectious com
plications, was reflected in restoration of
cutaneous responses to normal with no sub
sequent mortality. These findings indicate
that the condition of the majority of these
patients was normal before the acute process
developed and that therefore abnormalities
in cell-mediated immunity had been ac
quired. Failure of improvement in cutaneous
response in these seriously ill patients was
associated with a high mortality.
In patients who did not require surgery
or in whom surgery was not indicated (e.g.,
patients with metastatic carcinoma), the in
cidence of sepsis and death was significantly
higher in those with anergy or relative
anergy. Many of these patients died of their
advanced cancer and had altered cutaneous
responses. Cancer or advanced age alone
did not account for the increased morbidity
and mortality.
Why should defects in cell-mediated im
munity be associated with infectious com
plications and a high mortality in surgical
patients? Classically, susceptibility to viral,
fungal and protozoal infections is increased
in patients with altered cell-mediated im
munity. However, the patients in this study
were infected with organisms (e.g., Esche
richia coli, Staphylococcus spp., Proteus
spp.) thought to be controlled by humoral
mechanisms. This implies that defects in
volving both cell-mediated and humoral im
munity may be present. Abnormalities in
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lymphocyte, monocyte or neutrophil func
tion have been implicated in decreased host
resistance.13’ 17> 18 Defects in cellular
metabolism may also cause a generalized
decrease in immune response and may be
related to nutritional deficiencies. We have
reported elsewhere19 a close association be
tween the state of nutrition and skin-test
reactivity. In addition, the serum of anergic
and relatively anergic patients has been
shown to inhibit neutrophil and lymphocyte
response in vitro.20' 21 Further investiga
tion and identification of the cause or causes
of anergy, it is hoped, will allow specific
treatment. The role of immunotherapy with
bacille Calmette-Guerin, levamisole, transfer
factor or opsonin therapy remains investiga
tional. Specific indications await controlled
clinical trials and quantitative in vitro as
sessment of treatment efficacy.
The detection of anergy or relative anergy
by simple skin tests is predictive of infection
and related mortality. Identification of these
high-risk patients is valuable to the clinical
surgeon. Preoperative measures directed at
improving nutritional status and at elimin
ating septic foci may help reduce the mor
bidity and mortality in these patients. Skin
testing postoperatively and sequentially
thereafter aids in monitoring the patients’
response to therapy. Failure of improval of
skin-test reactivity may indicate occult in
fection, undrained abscess or nutritional
deterioration.
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SELF-ASSESSMENT
SESAP II QUESTION
509. The finding of increased amounts of carcinoembryonic antigen (CEA) in the
blood
(1) suggests recurrent or residual cancer in a patient who has had a resection for
carcinoma of the colon
(2) may be associated with sigmoid diverticulitis
(3) may be associated with certain collagen diseases
(4) provides the basis for a reliable screening test for identifying patients with
carcinoma of the colon
For this question one or more of the answers given above is correct. Your answer should
be:
A
B
C
D
E

if
if
if
if
if

only 7, 2 and 3 are correct,
only 1 and 3 are correct,
only 2 and 4 are correct,
only 4 is correct,
all are correct.

For the critique of Item 509 see page 83 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Sylla
bus: Surgical Education and Self-assessment Program No. 2.)

when shock
threatens the lung
Solu-Medroi

helps reduce pulmonary
damage and Increase
survival rates.

• preserves lysosome and cell membranes, thereby preventing the release o f destructive
lysosomal enzymes3
• preserves platelets thereby reducing the risk of intravascular coagulation1
• preserves leukocyte integrity thereby helping to maintain the pulmonary architecture1
The recovery of patients in shock is often complicated by a pattern o f deteriorating pul
monary function, commonly described as shock lung. This pulmonary insufficiency
progresses despite restoration of haemodynamic balance and apparent stabilization of
the acute episode.
Cinder conditions o f prolonged shock, lack of oxygen at the cellular level causes
alterations in the oxygen-carbon dioxide exchange mechanism. T hese
changes in cell metabolism lead ultimately to interstitial oedema and peri
vascular haemorrhage.1Polymorphonuclear leukocytes aggregate in
the pulmonary capillaries and obstruct the pulmonary vascular
bed. As these trapped cells break down, they release lysosomes, tiny subcellular particles containing proteolytic
enzymes.1These enzymes attack their host cell and
go on to damage or destroy other cells.2 The re
sulting tissue damage may not readily repair
itself even if the shock patient survives.
When administered in conjunction with
standard therapeutic measures, SoluMedrol exerts a protective effect
on the lung and improves the
patient’s chance o f survival.
Prescribing information on page 24
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GLIMPSES OF SURGICAL HISTORY:
M FOR MICROSCOPY

In the treatment of shock
and its pulmonary
complications

Solu-Mednol
soon enough, often enough,
in pharmacologic doses
Dosage and Administration: In treating severe
shock, there is a tendency in current medical
practice to use massive (pharmacologic) doses
o f corticosteroids. (The anti-inflammatory ac
tivity o f 1 m g o f Solu-Medrol is equal to 4 m g
or m ore o f hydrocortisone.)
The suggested dosage of Solu-Medrol for
severe sh ock is 30 m g /k g stat and repeated in
four hours, if necessary.
Therapy is initiated by administering SoluMedrol intravenously over a period o f at least
ten minutes. In general, therapy should be c o n 
tinued only until the patient’s condition has
stabilized — usually not beyond 48 to 72 hours.
Solu-Medrol may be given by intravenous in
jection, by intravenous infusion, or by intra
muscular injection. The preferred m ethod for
initial em ergency use is intravenous injection.

Cautions: The general precautions and co n 
traindications to systemic corticosteroid therapy
should apply to the use of Solu-Medrol. How
ever, when used for medical emergencies, or
in shock-like states, the possible lifesaving ef
fects m ust be weighed against the possible
undesired hormonal effects. In the treatment
o f shock, Solu-Medrol should be adjunctive to
conventional supportive therapy such as fluid
replacement, etc. Although adverse effects as
sociated with high-dose short-term corticoid
therapy are u ncom m on, peptic ulceration
may occur.
Supplied: As Solu-Medrol (methylprednisolone
sodium succinate) in 40 mg and 125 mg
Mix-O-Vials; 500 mg and 1 g vials with water
for injection.
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DAVID A. E. SHEPHARD
Osier was just one o f countless physicians
who not only have relied on M ICROSCOPY
in their work but also have delighted in natural
marvels so revealed. F or Osier the micro
scope brought a barrel o f water alive when
he observed “ the dim outline o f some little
creature kicking and struggling as though it
were caught in a net” — a description re
sembling that o f a microscopist who earlier
had seen, in a scraping o f his own teeth,
"little animals, more numerous than all the
people in the Netherlands, and moving about
in the most delightful manner” .
This microscopist was van Leeuwenhoek.
A 17th-century Dutch merchant, he invented
the simple microscope — and discovered red
blood cells.
Earlier another Dutchman,
Zacharias Jansen, had discovered the prin
ciple o f the compound m icroscope (he put
two o f his father’s spectacle lenses together
in an idle moment), and a third layman,
Robert H ooke, curator o f London’s Royal
Society, laid the scientific foundations o f the
science o f microscopy with publication o f his
classic work, “Micrographia” . These three,
and the Jesuit, Athanasius Kircher, who saw
“an innumerable Swarm o f W orms” in a blood
film taken from a patient with plague, helped
to make the 17th century the dawning o f a
new age o f science.
Man looked at the world in a new way.
M oreover, new ideas were recorded publicly;
and it is interesting that “Micrographia” was
published in 1665, when the first two scienti
fic journals (le Journal des Sjavan s and P h ilo
sophical Transactions) were created. A new
force was at work, which found expression in
language that all could understand. Just as
Osier later saw “som e little creature kicking
and struggling” in water, so H ooke trans
mitted his delight at the real beauty of simple
objects now transformed fo r man by the mi
croscope. If so plain an object as a razor had
an edge “like a plowed field, full o f ridges
and furrows” , could there be any limit to the
unfolding o f the flow er o f science?
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ADJUVANT IMMUNOSTIMULATION IN MALIGNANT MELANOMA
WITH ORAL BACILLE CALMETTE-GUERIN*
ALASDAIR B. MacGREGOR, MB, FRCS(Edin), RUDOLF E. FALK, MD, FRCS[C],
SILVIO LANDI, PhD, ULO AMBUS, MD, FRCS[C], EFRAIM S. S. SAMUEL, MD
and BERNARD LANGER, MD, FRCS[C], FACS
Results of the administration of oral bacille Cal
mette-Guerin (BCG) as an adjunct to standard
treatment in 62 patients with malignant mela
noma indicate that this drug is of value in pre
venting distant spread of the disease when it
is limited to one region and in its early stages.
BCG increases survival in patients with visceral
metastases. In those in whom these metastases
are surgically resectable, it inhibits the develop
ment of further metastases. Oral BCG treatment
does not affect the course of the disease in
patients with massive hepatic or intracranial
metastases.
Les resultats chez 62 patients de ('administra
tion par voie orale du bacille Calmette-Guerin
(BCG) comme therapie d'appoint au traitement
courant du melanome malin indiquent que ce
vaccin est utile pour prevenir la dissemination
a distance de cette maladie lorsqu’elle est locaiisee et dans ses premiers stades devolution.
Le BCG prolonge la survie des patients atteints
de metastases visceraies. Chez les patients
dont les metastases peuvent etre soumises a
une resection chirurgicale, il inhibe la croissance de nouvelles metastases. Le BCG administre par voie orale ne modifie pas 1'evolution
de la maladie chez les patients atteints de me
tastases massives hepatiques ou intracraniennes.

The continued interest in immunostimulation therapy for patients with solid tumours
has prompted us to report further studies of
malignant melanoma. In 1975 we presented
the results of our use of adjuvant treatment
with oral bacille Calmette-Guerin (BCG) in
47 patients with malignant melanoma.1 We
indicated that oral BCG was valuable in
preventing local recurrence and dissemina
tion from local disease, and that survival
*From the department of surgery, University of
Toronto, and the Toronto General Hospital, To
ronto, Ont.
Supported by the National Cancer Institute of
Canada, the Medical Research Council of Canada
and the Ontario Cancer Treatment Research
Foundation.
Reprint requests to: Dr. R. E. Falk, Room 100,
University Wing, Toronto General Hospital, To
ronto, Ont. M5G 1L7.

time was prolonged in patients with dis
seminated melanoma without intracranial
metastases. The survivors of this group have
been followed for a further year and 15 new
patients have been added. The present study
(ending May 31, 1976) confirms the original
observations; it further emphasizes the
benign nature of the treatment in contrast
to occasional serious complications en
countered with adjuvant chemotherapy.
A dministration of BCG
The BCG strain was derived from the
original Pasteur strain produced by Con
naught Medical Research Laboratories. The
standard oral dose was 120 mg, reconsti
tuted in nonbacteriostatic normal saline solu
tion (live colony organism count, 107/m g
moist weight) and administered to the pa
tient in orange juice. The dosage was de
creased if gastrointestinal side effects oc
curred. BCG was given either weekly or
every 2 weeks for 2 months — the more fre
quent dosage being used in patients with
negative skin tests. After 2 months, the in
terval was increased to once monthly. In pa
tients who remained disease-free at 1 year,
the interval between treatments was in
creased to 3 months. If the melanoma re
curred or obviously progressed, the interval
between treatments was decreased.
P atient G roups
The 62 patients were divided into five
groups depending on the stage of disease at
the beginning of treatment: group 1, 21
patients (9 women, 12 men; average age,
39.8 yr) with local disease only — stages 0,
1 and 2 according to the M. D. Anderson
Hospital classification; group 2, 18 patients
(10 women, 8 men; average age, 47.9 yr)
with metastases to regional lymph nodes or
in transit melanoma — stage 3; group 3, l l
patients (6 women, 5 men; average age,
47.1 yr) with disseminated melanoma —
stage 4, but excluding intracranial meta
stases; group 4, 6 patients with intracranial

26

THE CANADIAN JOURNAL OF SURGERY

metastases; and group 5, 6 patients with
primary intraocular melanoma, with or
without metastases.
R e su l t s

Group 1
Seventeen of the 21 patients began treat
ment with BCG within 2 months of diag
nosis of malignant melanoma, 2 within 6
months and 2 patients, with stage 2 disease,
at 4 and 8 years, respectively (Table I). At
the time of writing (May 31, 1976) all pa
tients are alive; the mean survival from the
start of treatment is a little less than 2
years. The disease recurred in six patients
during treatment, two with level 4 (stage 1)
invasion (out of six patients), the three pa
tients with stage 2 disease and the one with
multifocal disease.
Axillary tumour recurred in one patient
(no. 14) 15 months after primary excision.
It was treated by axillary dissection (3 of
31 lymph nodes involved) followed by in
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traperitoneal BCG and two courses of dacarbazine. Oral BCG was continued every
2 weeks but after 5 months recurrent tu
mour at the primary site required excision.
He received a third course of dacarbazine
but yet another axillary lesion developed
and required excision. He has no evidence
of distant spread.
Axillary and supraclavicular spread de
veloped in patient 18 after 27 months of
treatment (2 mg of BCG, intraperitoneally,
combined with monthly courses of dacar
bazine and oral BCG), which included a
6-month remission. He underwent forequar
ter amputation because of brachial plexus
involvement, and is apparently disease-free.
In patient 15 recurrent tumour in a local
lymph node 8 months after the start of
therapy was treated by inguinal node dis
section and dacarbazine. At present, he is
apparently tumour-free.
Local recurrence occurred at two sites in
each of two patients (nos. 19 and 20). In
patient 19 the lesions were excised. In-

TABLE I.—P atient D ata and R esults in G roup 1 — Stages 0 ,1

and 2

M alignant M elanoma
Survival, mo

Patient
no.

Age, Stage
Sex y r
or level

Interval
Recurrence
f r o m ----------------------------diagnosis
Before
During
to BCG
BCG
BCG
treatment, mo treatment treatment

1
2
31
4
5
6
71
8
9
10
11
12
13
14

M
M
F
F
F
F
F
F
M
M
F
M
F
M

38
32
27
53
54
18
57
49
34
32
39
60
18
37

Level 1
Level 1
Level 2
Level 2
Level 2
Level 3
Level 3
Level 3
Level 3
Level 3
Level 3
Level 4
Level 4/5
Level 4

0
1
0
0
0
6
6
0
1
0
2
0
2
1

—

3

15

M

60

Level 4

1

—

1

16
17
18

M
M
M

25
41
52

Level 4
Level 4
Stage 2

0
1
2

—

—

—

—

19

M

36

Stage 2

20
21

M
F

38 Stage 2
35 Multifocal

22
36
33
10
28
40
40
34
24
19
14
34
24
23

22
35
33
10
28
34
34
34
23
19
12
34
22
22

10

9

—
5
Dacarbazine
5
Excision, dacarbazine, 37
intraperitoneal BCG
Autologous and
120
allogeneic
cells, excision
Dacarbazine
82
Excision,
26
dacarbazine

5
4
35

__

___

__

—

—

—

—

—

—

—

—

—

—

—

_

_

—

—

—

—

—

—

—

_

—

—

_

—

—

—

—

—

_

—

_

—

—

_

_

1

1

94

2

2

48
0

2
“

*Mean = 31.7 mo.
(Mean = 23.9 mo.
(BCG caused gastrointestinal side effects.

Other
treatment

From
start of
From time of BCG
diagnosis* treatment]

2
Multiple

Excision, dacarbazine,
intraperitoneal BCG
Excision,
dacarbazine

26
34
26
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guinal lymph-node biopsy gave negative re
sults. This patient was twice treated with
autologous and allogeneic irradiated mela
noma cells. He is receiving oral BCG and
has been disease-free for 5 months. In pa
tient 20 excision was followed by monthly
treatment with dacarbazine for 6 months in
addition to oral BCG. He has remained free
of disease for 13 months.
The condition of the sixth patient with
recurrent tumour was discussed in detail
previously.1 She had an excisional biopsy
of the tongue in January 1974, followed
by oral BCG treatment and hemiglossectomy in February 1974. Despite continued
TABLE II.—P atient D ata and R esults

P a tie n t
no.

In terva l
fr o m
S u rv iva l
dia g nosis
f r o m tim e
to B C G
o f diagnosis,
A g e,
treatm ent, m o
mo
Sex yr

in

treatment, local and distant recurrence de
veloped requiring radical neck dissection
and hemimandibulectomy in July 1974. Sec
ondary tumour in the lung responded par
tially to the administration of dacarbazine
monthly and oral BCG weekly. In Septem
ber 1975, the secondary lesion was excised,
but 5 months later multiple lung and skin
metastases were present and the disease is
now out of control.
Group 2
Of the 18 patients in this group, 17 had
regional lymph-node metastases at the start
of treatment with BCG; 1 had in-transit
G roup 2 - Stage 3 M alignant M elanoma

N o . o f opera tio n s
B efo re
D u r in g
BCG
BCG
tre a tm en t treatm ent

22*

F

38

80

107

2

2

23

F

36

72

82

2

1

24

M

17

38

50

2

—

25
26

F
M

62
59

21
36

59
40

3
1

5
—

27

F

47

24

36

2

1

28

F

35

24

28

3

1

29

M

77

3

23

30

F

58

8

21

3

31

M

59

9

19

2

1

32

M

71

9

15

1

—

33
34*
35
36

M
F
M
F

29
47
56
58

4
102
35
34

36
111
50
47

1
2
2
2

37

F

35

19

23

4

—

38

M

36

11

21

3

—

39

F

48

0

12

1

1

*BCG caused gastrointestinal side effects.
|Dacarbazine caused side effects.

27

4

—
—
—

Other
treatm ent

O utcom e

Autologous cells, Died: pulmonary
dacarbazine
metastases
Died: myelosuppresDacarbazine,!
carmustine
sion causing bleed
ing into intra
cranial secondary
Dacarbazine
D ied: liver metas
tases
Dacarbazine
Alive: disease stable
None
Died: intracranial
metastases
None
Died: pulmonary
embolism after
ventriculoperi
toneal shunt
None
D ied: multiple me
tastases
Autologous cells Initially refused
treatm ent. Died:
progressive mela
noma
Dacarbazine
D ied: transient re
missions of 2 and
1 mo
Autologous and D ied: progressive
allogeneic cells, disease
dacarbazine
None
Died: multiple
metastases
None
Alive: disease-free
None
Alive: disease-free
Dacarbazine,
Alive: disease-free
Dacarbazinef
Alive: disease-free
intradermal
BCG
Dacarbazine,
Died: multiple
carmustine
metastases
Dacarbazine
Died: multiple
metastases
Dacarbazine,
Alive: lymph-node
carmustine
biopsy negative.
Disease-free
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metastases. The interval between initial
diagnosis and the start of treatment (Table
II) did not appear to affect survival.
At the time of writing six patients in this
group are still alive; their mean survival is
52.5 months from the time of diagnosis
and 19.8 months from the start of BCG
treatment. The mean survival for all patients
in this group is 43.3 months from diagnosis
and 13.9 months from the start of treatment,
compared with 39.5 months and 12.2
months respectively in our previous report.1
Five patients had residual disease at the
start of treatment; their average survival was
9.4 months.
One survivor (no. 25) had five resections
of tumour while on treatment and also re
ceived dacarbazine. She still has slowly
progressive local tumour but no evidence
of dissemination. Two survivors (nos. 33
and 34) had no other treatment and remain
apparently free of disease. Two more (nos.
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35 and 36) were treated with dacarbazine;
patient 36 received intradermal BCG and
dacarbazine in addition to oral BCG. This
patient had a severe reaction to dacarbazine,
with nausea, vomiting, diarrhea and severe
phlebitis at the site of injection. Both pa
tients are free of disease, as is patient 39,
who was treated with two courses of dacar
bazine and carmustine.
Two of the patients who were alive when
last reported1 have since died. Patient 22,
who had metastatic disease, died of pul
monary metastases. Multiple skin metastases
developed in patient 23. These were excised
and she was treated with one course of da
carbazine and carmustine. She died from
hemorrhage into an unsuspected intracranial
metastasis induced by severe myelosuppression following the chemotherapy. The addi
tion of other forms of treatment, such as
chemotherapy and immunostimulation with
autologous or allogeneic irradiated mela-

TABLE III.—P atient D ata and R esults in G roup 3 - S tage 4 M alignant M elanoma but E xcluding
I ntracranial M etastases
Interval
from
Survival
diagnosis from lime of
Patient
to BCG
Age,
diagnosis,
no.
Sex yr treatment, mo
mo

No. of operations
Before During
BCG
BCG
treatment treatment

40

F

29

79

104

2

3

41

F

61

84

107

3

2

42

M

54

84

89

2

1

43

F

36

50

59

4

—

44
45*

M
F

60
43

10
0

46
29

1
1

1
6

46

F

20

20

29

2

3

47

M

59

4

6

3

—

48

M

74

0

4

—

—

49

F

42

114

117

2

50

M

40

17

26

2

*BCG caused gastrointestinal side effects.
(Dacarbazine caused side effects.

1

Other treatment
Chemotherapy
before BCG,
autologous and
allogeneic cells
Autologous cells,
dacarbazine
Autologous cells,
intratumour
BCG
Intratumour
BCG
Dacarbazine
Autologous and
allogeneic cells,
dacarbazine
None

Outcome
Died: progressive
disease
Alive: in remission
Died: progressive
disease
Died: progressive
disease
Alive: in remission
Died: progressive
disease

Died: progressive
disease
Died: progressive
disease
Intratumour
Died: progressive
BCG
disease
Dacarbazine,)
Died: myelosupprescarmustine, in sion, minimal re
tradermal
sidual disease
BCG
Dacarbazine,
Died: progressive
carmustine,
disease
intradermal
and intraperitoneal BCG
None
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noma cells, does not appear to have pro
longed survival in this group.
Group 3
All 11 patients in this group (Table III)
had disseminated melanoma at the start of
treatment with BCG. Five had visceral
spread, two had spinal metastases and in
the remaining four the disease had spread
beyond the regional lymph nodes. Mean
survival was 56 months from the time of
diagnosis and 14 months from the start
of treatment with BCG.
Nine patients died, seven as previously
reported1 from progressive disease. The
two new patients added to this group both
died; in patient 49 the disease had spread
to the ipsilateral supraclavicular lymph
nodes from a primary melanoma in the arm.
She was treated with two courses of dacarbazine and carmustine as well as oral and
intradermal BCG. The second course was
followed by severe myelosuppression, sys
temic candidiasis and death from massive
hemoptysis. There were small foci of mela
noma in the supraclavicular glands only.
The other patient (no. 50) started BCG
treatment after resection of bony metastases
from the lumbar spine with spinal fusion
and radiotherapy. He failed to respond to
treatment with dacarbazine and carmustine
as well as oral, intradermal and intraperitoneal BCG. He required a second laminec
tomy and spinal fusion for pain and eventu
ally died of metastatic melanoma.
There were two survivors from the
original series (nos. 41 and 44). Patient 41
had deposits in the leg requiring resection
and two courses of dacarbazine. She re
mains free of disease and is receiving oral
BCG only. Patient 44 had a resection of
supraclavicular lymph nodes and one
course of dacarbazine. He also remains free
of disease and is receiving oral BCG.
Groups 4 and 5
The patients with intracranial metastases
in group 4 were previously reported1 and
no new patients were added to this group.
The addition of oral BCG treatment in this
group had no influence on survival (mean,
5.3 mo from the start of BCG treatment).
One new patient with intraocular mela
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noma with metastases was added to group 5.
The previous five patients all died (mean
survival, 2.4 mo from the start of treat
ment); the cause of death in all was hepatic
metastases. The new patient is a 60-yearold man who had had enucleation for intra
ocular melanoma 7 years previously. A
chest wall mass was resected; it was a sec
ondary melanoma involving the fourth rib
and surrounding muscle. After operation,
he was treated with dacarbazine, carmustine,
and intraperitoneal BCG (2 mg); subsequent
ly he received maintenance therapy with oral
BCG. He has remained free of disease for
11 months.
D iscussion

Nonspecific immunostimulation in the
management of patients with malignant
melanoma is becoming established. A re
cent report by Eilber and colleagues2 re
vealed that in patients with stage 2 malig
nant melanoma, the combination of opera
tion and BCG treatment was superior to op
eration alone, both in decreasing the propor
tion of patients in whom recurrence devel
ops by up to 50% and in delaying the on
set of metastases by a mean of 6 months.
Treatment was less effective in those with
jnultiple lymph-node involvement.
An alternative method of treatment is
limb perfusion with hyperthermia, recently
reported by Stehlin and associates.3 This
method produced a 5-year survival rate of
83.5% in stage 1 disease. In patients with
regional recurrence or metastases clinically
confined to an extremity, the 5-year survival
rate was 48.2% . This method is limited to
melanoma of the extremities and would not
have been applicable in 10 of our group 1
patients who had melanoma of the trunk or
head and neck.
In none of our patients with' level 1 to
3 (stage 1) disease has a recurrence de
veloped (mean follow-up, 25.8 mo). Only
two of six with level 4 invasion have
had recurrent disease; in one the disease
has spread to the supraclavicular nodes. In
the patient with multifocal disease, pul
monary metastasis became apparent 8
months after the treatment began, but was
well controlled by a combination of oral
BCG and dacarbazine; the lesion was re
sected 13 months later. Thus it appears that
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oral BCG is useful in limiting the dissemina
tion of tumour beyond the primary region
in patients with stages 1 and 2 malignant
melanoma. These findings agree with those
of Eilber and colleagues,- who administered
Tice strain of BCG intradermally.
Of the 17 patients in group 2 with lymphnode involvement, 10 had melanoma of the
trunk or head and neck. The patient with in
transit metastases had melanoma of the leg.
All the patients who died had metastatic
disease. One patient died as a consequence
of myelosuppression, which led to bleeding
into an unsuspected intracranial metastasis.
In each patient with lymph-node involve
ment melanoma had invaded many nodes,
placing these patients at high risk of early
recurrence. Treatment with oral BCG with
or without chemotherapy resulted in a mean
survival of 19.8 months (range, 9 to 38 mo)
in the six who are still alive, all but one of
whom are free of disease.
In group 3, patients with disseminated
melanoma but no intracranial metastases,
the mean survival was 14 months compared
with 4 months reported by Einhorn and col
leagues.4 Two patients out of 11 are alive
at 23 and 36 months. Both required further
resection and treatment with chemotherapy
in addition to oral BCG; both had local or
regional nodal recurrences. This finding in
dicates further that, in some patients, oral
BCG is effective in preventing distant
metastases.
Our previous results showed that BCG
did not affect the course of patients with
intracranial or massive hepatic metastases.
In the one patient with a solitary chest wall
recurrence from intraocular melanoma, a
combination of chemotherapy and oral and
intraperitoneal BCG controlled the disease.
The results obtained in this series and
that of Eilber and colleagues- show that
adjunctive treatment with BCG is effective
in controlling recurrence and dissemination
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of malignant melanoma. It is of greatest
value in the early stages when all the tumour
can be resected but is also of use when the
tumour burden has been reduced to a mini
mum or eliminated by surgery in patients
with metastases. Oral administration is easy
and has minimal side effects. The results
are comparable to those achieved by the
intradermal route. The intraperitoneal route
has been used without side effects in four
patients to reinforce oral BCG. Three pa
tients have received intradermal BCG with
out any obvious improvement in survival.
It is difficult to assess the effect of the
addition of chemotherapy to the treatment
regimen in this series of patients, although
favourable results have been reported by
Gutterman and associates.5 While dacarbazine alone produced a severe reaction in
only 1 of 17 patients, the combination of
carmustine and dacarbazine caused severe
myelosuppression in 2 of 6 patients. This
combination did not influence survival in
the few patients in whom it was used and
therefore should be used with extreme
caution.
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Correction
On page 557 of the November 1976 issue of the Journal the legend for the photograph
of the presentation of the first Davis & Geek Surgical Essay Award should read “Mr.
D ave Smith, marketing manager of Davis & Geek, Division of Cyanamid of Canada
Limited, presents a cheque . .

January 1977

THE CANADIAN JOURNAL OF SURGERY

33

SPONTANEOUS AORTOCAVAL FISTULA SECONDARY TO RUPTURED
ABDOMINAL AORTIC ANEURYSM*
A. S. LIVINGSTONE, MD, C. I. CHIU, MD, PhD, FRCS[C],
D. S. MULDER, MD, FRCS[C] and H. J. SCOTT, MD, FRCS[C]
Two patients with the rare condition of sponta
neous aortocaval fistula secondary to ruptured
abdominal aortic aneurysm were treated suc
cessfully by surgical closure of the fistula. In
view of the existing controversies on certain
aspects of the pathophysiology involved, canine
experiments were performed to elucidate the
pathogenesis of regional venous hypertension
and hematuria observed in these patients. The
experiments demonstrated that regional venous
hypertension is a purely rheologic phenomenon
and that hematuria originates from a congested
lower urinary tract.
Deux patients presentant une affection rare, une
fistule aorto-cave spontanee secondaire a la
rupture d'un anevrisme de I’aorte abdominale,
ont ete traites avec succes par fermeture chirurgicale de la fistule. Vu la controverse actuelle
concernant certains aspects de la pathophysiologie impliquee, des experiences chez des
chiens ont ete effectuees dans le but d’elucider
la pathogenese de ('hypertension veineuse re
g io n a l et de I’hematurie observees chez ces
patients. Ces essais ont demontre que I'hypertension veineuse regionale est un phenomene
purement rheologique et que I’hematurie provient d'une congestion du tractus urinaire inferieur.

right-sided flank pain that spread down the
right leg; a few hours later the left leg became
uncomfortable. Both legs were swollen and
appeared bluish as did the pelvis and lower
abdomen. Hematuria was noted on admission.
His blood pressure was 160/60 mm Hg and
the pulse rate 130 beats/min. Physical exam
ination revealed a pulsating mass in the mid
abdomen that was not readily palpated at
first owing to obesity; the abdomen was not
tender. Peripheral pulses were strong. There
was no sign of ischemia but venous engorge
ment of the legs was evident beginning just
below the umbilicus and involving both lower
extremities. The distended leg veins did not
collapse when the legs were elevated. A Foley
catheter drained large quantities of bloody
urine. The central venous pressure was 0 to
2 cm H2iO. Intravenous pyelography demon
strated normally functioning kidneys with dis
placement of the right ureter laterally by a
mass. Angiography revealed an abdominal
aortic aneurysm with a fistula to the inferior
vena cava (Fig. 1).

S po n t a n e o u s aortocaval fistula, though
relatively rare, is an often fatal complication
of abdominal aortic aneurysm.1"8 We
report the successful management of this
condition in two patients by emergency
operation and describe the results of an
experimental study that appears to resolve
existing controversies related to the patho
physiology of this condition.
C ase R eports
Case 1.—A previously healthy 62-year-old
man complained of the sudden onset of severe
*From the division of cardiovascular and thoracic
surgery, department of surgery, McGill University,
Montreal General Hospital, Montreal, PQ.
Supported by grants from the Medical Research
Council of Canada.
Reprint requests to: Dr. C. J. Chiu, Division of
cardiovascular and thoracic surgery, Montreal
General Hospital, 1650 Cedar Ave., Montreal, PQ
H3G 1A4.

Fig. 1.—Case 1. Aortogram (lateral view) dem
onstrating contrast media in aortic aneurysm and
inferior vena cava.

34

THE CANADIAN JOURNAL OF SURGERY

At laparotomy we found an aortic aneurysm
(length, 15 cm) below the renal arteries and
a fistula (length, 4 cm) extending from the
aneurysm into the inferior vena cava just above
the level of the bifurcation. Proximal and
distal aortic clamps were applied and the
aneurysm was entered; digital pressure con
trolled caval bleeding. The fistula was closed
from within the aneurysm. A woven Dacron
prosthesis was inserted from the infrarenal
aorta to both external iliac arteries. The hema
turia had cleared by the end of the procedure
and the postoperative course was uncom
plicated.
Case 2.— A 57-year-old man with no per
tinent previous medical history was admitted
with increasingly severe, nonradiating, low
back pain for 2 days and gross hematuria.
Swelling of both legs was first noted 24 hours
before admission. His blood pressure was
130/SO mm Hg and his pulse rate 100
beats/min. An abdominal aortic aneurysm was
palpated in the midline extending towards the
right lower quadrant. There was local tender
ness. A continuous grade 4/6 bruit was heard,
loudest in the right lower quadrant. All peri
pheral pulses were strong. There was severe
venous congestion and edema of both legs. The
diagnosis of aortocaval fistula was made from
the clinical findings alone. At operation an
aneurysm (length, 13 cm) below the renal ar
teries extended bilaterally into the iliac arteries.
A fistula (length, 4 cm) extended from the
aneurysm at the bifurcation into the right com
mon iliac vein at its junction with the inferior
vena cava. The fistula was closed as described
in Case 1 and the aneurysm was replaced with
a bifurcated Dacron aortobifemoral graft. The
postoperative period was uneventful except for
a period of hypertension soon after the opera
tion; the hypertension was controlled initially
by an intravenous nitroprusside infusion and
subsequently with methyldopa (Aldomet).
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ing both lower extremities and the lower
abdomen. They complain of low back, ab
dominal and occasionally leg pains and
often have gross or microscopic hematuria.
The prognosis of untreated patients with
such fistulas is poor.1 3- 4 Although they
may eventually die from heart failure due to
the massive arteriovenous shunt, the venous
hypertension appears to be confined initially
to the lower extremities and the pelvis.
To explain these findings, a number of
authors have postulated that the bulging
aortic aneurysm cephalad to the aortocaval
fistula compresses the vena cava above the
fistula, directing the shunt flow towards the
lower extremities.5’ 6 It was argued that
such a phenomenon is peculiar to the aorto
caval fistula secondary to the ruptured ab
dominal aortic aneurysm, and that pathophysiologically it differs from traumatic
aortocaval fistula. The pathogenesis of
hematuria was also debated. DeBakey and
colleagues7 studied renal function before
and after the repair of aortocaval fistulas.
The fistulas decreased the renal plasma flow
substantially, although the glomerular filtra
tion fraction was increased and thus the glo
merular filtration rate remained normal. On
the other hand, in patients with spontaneous
aortocaval fistula associated with abdominal
aortic aneurysm, the gross and microscopic
hematuria had been attributed to severe
pelvic venous hypertension, implicating the
lower urinary tract as the source of hema
turia.8 In view of such controversies, we
performed canine experiments to determine:
(a) the pressure gradient in the inferior vena
cava in the presence of a large aortocaval
fistula without aneurysm and (b) the source
of hematuria.

Comment
Spontaneous aortocaval fistula secondary
to ruptured abdominal aortic aneurysm is
relatively rare, approximately 50 cases
having been reported in the literature.1 In
one series of approximately 1400 abdominal
aortic aneurysms surgically managed (of
which 130 had already ruptured),2 four
aortocaval fistulas were encountered. These
patients usually present with a unique syn
drome of a pulsatile abdominal mass and
marked regional venous hypertension involv

C anine E xperiments
Three mongrel dogs (weight, 18 to 20 kg)
were anesthetized with intravenous pento
barbital (30 mg/kg) and intubated. A poly
ethylene catheter was advanced into the
inferior vena cava through the right saphen
ous vein and connected to a Statham strain
gauge and a Grass recorder. The right ureter
was cannulated through a midline lapar
otomy incision, with the tip of the catheter
in the right renal pelvis; the ureter was
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hours, blood appeared in the bladder urine
with congestion and edema of the ureter
and urinary bladder, whereas urine from the
right kidney remained clear. Occlusion of
the aorta proximal to the fistula cleared the
urine of blood within a short period of time.
At autopsy, the kidneys were not congested,
whereas the pelvic organs were edematous
with intramucosal hemorrhage in the ureter
and urinary bladder.
D iscussion
IVC PRESSURE
A=Aorto
F=Fistula

3Z=Wna Cava
B=Urinary Bladder

Fig. 2.—Canine experimental model and results,
illustrating pressure gradient in inferior vena cava
and development of hematuria from lower urinary
tract.

ligated and divided at the ureteropelvic
junction. Another catheter was placed into
the urinary bladder through a suprapubic
cystostomy. Urine from both the right kid
ney and the bladder was collected in sep
arate tubes and observed for the appearance
of hematuria. A portion of the infrarenal
abdominal aorta (length, 1.8 cm) was anas
tomosed side to side to the inferior vena
cava. Pull-through pressure recordings were
obtained in the inferior vena cava: the
caval catheter was advanced to the level of
the diaphragm and, under continuous pres
sure monitoring, was gradually withdrawn
towards and below the fistula. Fig. 2, re
presenting a tracing obtained from such
pressure monitoring, shows normal venous
pressure in the inferior vena cava above the
fistula, a slight decrease in the venous pres
sure with turbulence just above the level
of the fistula and a sharp increase of inferior
vena caval pressure, becoming identical to
the aortic pressure, when the catheter
tip reached the level of the fistula and
below. These pressure changes were con
firmed by the visual observation of the in
ferior vena cava, which was normal and
collapsing above the fistula and distended
and pulsating below.
Urine from both the right kidney and the
bladder was clear before the establishment
of the aortocaval fistula. Within minutes to

Although the hypothesis that the aortic
aneurysm compresses the vena cava above
the fistula and causes shunt flow to be
directed towards the lower extremities is
plausible, no direct proof has been demon
strated.50 The initial clinical impression
that such regional venous hypertension is
unique and is not seen in traumatic aorto
caval fistula has not been substantiated by
recent observations.1 There has been no
angiographic confirmation of caval com
pression either in our patient or in those
reported previously. Nor have we been im
pressed by clinical signs of inferior vena
caval compression in other patients with
large abdominal aortic aneurysms.
Our experimental study clearly indicates
that the phenomenon of regional venous hy
pertension in the lower extremities is pri
marily hemodynamic. The great velocity of
blood flow in the aorta and the parallel ana
tomical arrangement of the aorta and the
vena cava direct the blood flow caudad to
wards the veins in the lower extremities as a
purely rheologic phenomenon. The slight de
crease in the pressure and the turbulence
just above the fistula that we observed is
consistent with such a rheologic concept.
Furthermore, our experiments indicate that
the renal veins are protected from abnormal
ly high pressure, and the hematuria indeed
originated from the congested lower urinary
tracts. Therefore we conclude that there is no
basic pathophysiologic difference between
traumatic aortocaval fistula and fistula asso
ciated with an aortic aneurysm. The different
clinical courses described in the past5 can be
attributed to the size of the fistula, the dif
ference in age of the patients in the two
groups and the condition of the cardio-
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vascular system, since the spontaneous
aortocaval fistula secondary to aortic aneur
ysm occurs mostly in elderly patients with
advanced arteriosclerosis. The average sur
vival of patients with spontaneous aorto
caval fistula not treated surgically is
approximately 20 days (range, 2 h to 2
mo).1
Clinical awareness of this unique syn
drome can lead to prompt diagnosis, often
from clinical findings alone, and early sur
gical intervention should save many of these
patients.
We thank Dr. Milton J. Herba, radiologist, who
performed the aortography.
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TOXIC MEGACOLON: RESULTS OF EMERGENCY COLECTOMY*
S. C. PATEL, MB, BS, FRCS[C] and R. M. STONE, MD, FRCS[C]
In order to assess the results of emergency
colectomy for toxic megacolon in ulcerative coli
tis, the records of 40 patients treated over a 16year period w ere reviewed. The diagnosis of
toxic colon was confirmed by a combination of
clinical, radiologic, operative and pathologic
examinations. Steroids were part of the treat
ment before operation in 36 patients. The sur
gical procedures included subtotal colectomy in
37 patients and total proctocolectomy in 3. Fecal
spillage was recognized in 10 procedures. Two
patients died postoperatively, but in neither had
fecal contamination been observed. The findings
of this review support the use of colectomy as
the surgical treatment for toxic megacolon.
Dans le but d'evaluer les resultats de la colectomie d'urgence pour un megacolon toxique lors
d'une colite ulcereuse, les dossiers de 40 pa
tients traites sur une periode de 16 ans ont ete
passes en revue. Le diagnostic de colon toxique
a ete confirme par une ensemble d'examens
cliniques, radiologiques, operatoires et patho-

*From the division of general surgery, Toronto
General Hospital, University of Toronto, Toronto,
Ont.
Reprint requests to: Dr. R. M. Stone, Division of
general surgery, Mount Sinai Hospital, 600 Uni
versity Ave., Toronto, Ont. M5G 1X5.

logiques. Les steroides ont fait partie du traitement pre-operatoire chez 36 patients. Les inter
ventions pratiquees comprennent une colectomie subtotale chez 37 patients et une proctocolectomie totale dans 3 cas. Un epanchement du
contenu intestinal a ete constate lors de 10
interventions. Deux patients sont decedes dans
la periode postoperatoire mais chez ni I’un ni
I'autre on n'avait observe de contamination fecale. Les observations decoulant de cette revue
soutiennent le recours a la colectomie comme
le traitement chirurgical du megacolon toxique.

Toxic megacolon may occur in patients with
nonspecific ulcerative colitis, granulomatous
colitis, amebic colitis, ischemic colitis, pseu
domembranous enterocolitis, typhoid fever,
bacillary dysentery and cholera. It is char
acterized clinically by dilatation of all or
part of the colon and severe systemic toxi
city; radiologically by colonic dilatation,
loss of h austral pattern and mucosal ulcer
ation; and pathologically by a transmural
necrotizing inflammatory process.
Conservative treatment of toxic mega
colon is associated with high mortality,
though adequate data are not available.
Operative treatment by emergency colec-
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tomy is also associated with a high mortality
(14 to 30)% ,! which is attributed to opera
tive manipulation and disruption of a
walled-off perforation with resultant fecal
contamination of the peritoneal cavity. Most
surgeons and gastroenterologists recommend
the surgical approach for this serious com
plication. Recently Turnbull, Hawk and
Weakley2 suggested that, in the presence of
a walled-off perforation, colectomy should
be abandoned in favour of a staged proce
dure consisting of an initial diverting ileos
tomy and multiple colostomies. Their report
led us to review our experience with colec
tomy and ileostomy.
P atients

and

M ethods

Clinical Material

Between Jan. 1, 1959 and Dec. 31, 1975,
700 patients with inflammatory bowel dis
ease were admitted to the Toronto General
Hospital. In 40 of these patients acute toxic
dilatation was present on admission or devel
oped while the patient was in hospital. The
diagnosis was based on the combination of
clinical, radiologic, operative and pathologic
findings; 39 patients had nonspecific ulcera
tive colitis and 1 had Crohn’s colitis.
There were 23 men and 17 women with
an age range from 16 to 79 years (mean,
31 yr). Thirty-two patients were under 40
years of age. The duration of the disease
was brief in most patients — 2 years or
less in 34 patients. Acute toxic dilatation
occurred during the first attack of ulcera
tive colitis in 18 patients; 22 had chronic
ulcerative colitis. The indications for opera
tion were as follows: free perforation; great
distension with cecal tenderness; pelvic or
left-sided peritoneal irritation; deterioration
in clinical status at any time within 48
hours; no significant improvement by 48
hours with vigorous conservative treatment.
Two patients presented with free perfora
tion and were operated on after appropriate
resuscitation. Initial management of the re
maining patients consisted of nasogastric
suction, intravenous fluid and electrolyte
therapy, blood replacement, systemic corti
costeroids, antibiotics and repeated clinical
and radiologic examination under the guid
ance of a surgeon and gastroenterologist.

37

Operative Details

All patients had an emergency operation.
Thirty-seven patients underwent subtotal
colectomy and ileostomy and three patients
had a one-stage proctocolectomy. The rectal
stump was oversewn in 13 patients and a
mucous fistula was created in 24.
Fecal contamination of the peritoneal
cavity was recognized in 10 patients at oper
ation. In two of these, perforation had oc
curred before the operation. In eight pa
tients, operative manipulation and disruption
of a sealed-off perforation were responsible
for fecal contamination. This disruption oc
curred during mobilization of the left colon
and proximal sigmoid.
The peritoneal cavity was drained in all
patients with fecal contamination and in
those in whom the rectal stump was over
sewn.
R esults
In 24 patients (60%) the postoperative
course was uncomplicated; major complica
tions developed in 14 (35% ) and 2 patients
(5% ) died. Both patients who died had had
a subtotal colectomy and ileostomy with a
mucous fistula. Fecal contamination at oper
ation was not recognized in either case.
Massive pulmonary aspiration on the 3rd
postoperative day was the cause of death
in one 18-year-old patient, and pneumonia
and progressive respiratory failure caused
the death of the other 79-year-old patient.
The major complications in the 14 pa
tients included intra-abdominal abscess (7),
wound dehiscence (5), massive bleeding
from the rectal stump (1) and mechanical
small-bowel obstruction (1).
Management of the rectal stump de
pended on the extent and severity of the
primary disease. In 18 patients, subsequent
rectal excision was necessary. Ileorectal
anastomosis was done at a later date in one
patient only.
D iscussion
Acute toxic dilatation of the colon con
stitutes a true surgical emergency. A delay
in diagnosis is still common. Management
during the acute stage should be the com-
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bined responsibility of a gastroenterologist
and a surgeon. Lack of clinical improvement
within 24 to 48 hours should be considered
as an absolute indication for surgical inter
vention. The overall mortality of this con
dition is still high and only a small unpre
dictable proportion of the patients recover
without operation. The importance of early
operation has been stressed in many recent
reviews.2' 6 In a collective review by Binder,
Patterson and Glotzer 7 an important deter
minant of mortality appeared to be perfora
tion of the colon. Early surgical intervention
may avoid this complication. The dangers
of peritoneal contamination during colec
tomy for fulminant ulcerative colitis are well
recognized.8' 10
Turnbull, Hawk and Weakley2 recom
mend a temporizing approach of the “blow
hole” procedure in situations where a
walled-off perforation exists. The problem
here is that it is not always easy to make
such a diagnosis without first mobilizing the
colon. The presence of edema extending
into the lateral gutters does not necessarily
mean that the colon cannot be removed
without fecal spillage.
The systemic toxicity exhibited by such
patients may not decrease until the colon
is removed. Anesthetic records often dem
onstrate a slowing of the pulse rate after
the colonic blood vessels have been ligated.
The “blow-hole” procedure necessitates a
subsequent operation to remove the colon
with resultant morbidity and mortality, but
may have a role in a patient who is mori
bund with severe peritoneal infection. In
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this series the 10 patients who had recog
nized fecal spillage at operation all survived
even though a major postoperative complica
tion occurred in most.
With early surgical intervention, colec
tomy may be performed with a low mortality
and is the treatment of choice in toxic
megacolon. The “blow-hole” procedure
should be reserved for the occasional patient
who is moribund.
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SPONTANEOUS PERFORATION OF THE BILE DUCTS IN INFANCY
JARLEY KOO, MB, ChB, FRCS[C],* ADRIAN B. JONES, MD, FRCP[C]t
and FRANK W. TURNER, MB, ChB, FRCS[C]
The clinical features of spontaneous perforation
of the bile ducts in infancy differ sufficiently
from those of other causes of neonatal jaundice
to allow early preoperative diagnosis as demon
strated by a report of this condition in a 6-weekold infant. Despite its rarity, the clinician should
be aware of this entity because early recognition
and surgery will ensure cure in almost all cases.
The cause of spontaneous perforation of the bile
ducts is unknown. Trauma, congenital weakness
and abnormal bile are considered as possible
etiologic factors.
Le tableau clinique d’une perforation spontanee
des canaux biliaires chez le nourrisson differe
suffisamment de ceux des autres causes
d’ictere du nouveau-ne pour permettre un dia
gnostic preoperatoire precoce, tel que le demontre un cas signale chez un bebe de 6
semaines. En depit de sa rarete, le clinicien
devrait etre conscient de cette affection car
son diagnostic precoce et la chirurgie en assurent la guerison dans presque tous les cas. On
ne connait pas la cause de la perforation des
canaux biliaires. Les facteurs etiologiques pos
sibles qui ont ete envisages sont le traumatisme, une faiblesse congenitale ou une bile
anormale.

Spontaneous perforation of the bile ducts
in infants is a rare but serious cause of
neonatal jaundice. It is usually confused
with biliary atresia or neonatal hepatitis;
often diagnosis is delayed or missed alto
gether. Since Caulfield1 reported the first
case in the English literature in 1936, only
isolated reports have appeared,2"3 and to
date fewer than 60 cases have been reported
in the world literature. An extensive review
of the condition was presented by Prevot
and Babut6 in 1970. In most cases diagnosis
was made only at operation or autopsy.
Delayed treatment was common and led to
unnecessary complications. Conservative
treatment usually ended in disaster. In this
’■'Department of surgery, University of Alberta
Hospital, Edmonton, Alta.; present address: c/o
Orthopedic clinic, Kwong Wah Hospital, Waterloo
Rd., Kawloon, Hong Kong.
tDepartment of pediatrics, University of Alberta
Hospital, Edmonton, Alta. T6G 2B7.
Reprint requests to: Dr. F. W. Turner, Depart
ment of surgery, University of Alberta Hospital,
Edmonton, Alta. T6G 2B7.

paper we report a case of spontaneous per
foration of the bile ducts in an infant and
review the literature to draw attention to
the clinical recognition of this rare condi
tion and its possible cause.
C ase R eport
A 6-week-old first-born male infant (birth
weight, 4.6 kg) was admitted with a history of
intermittent jaundice since birth, and non
productive cough and vomiting after feeding
for a week. The mother’s pregnancy was
normal throughout and delivery was accom
plished with forceps at 42 weeks. The infant
was mildly jaundiced at birth but the jaundice
subsided gradually and had disappeared at 3
weeks. The parents were not sure when the
jaundice returned; they did not notice any
change in the colour of the stool or urine.
Physical findings revealed a well nourished
baby with weight and height at the 90th
percentile. He was moderately jaundiced. The
abdomen was noticeably distended and there
was a left inguinal hernia. The liver and
spleen were not palpable. The hernial sac
appeared to be filled with fluid, suggesting the
possibility of ascites. Results of laboratory in
vestigations are listed in Table I.
TABLE I.—R esults

of P reoperative
gations

Investigation

Result

Hemoglobin, g/dl
Leukocyte count,
x 10»//
Reticulocytes, %
Serum:
Bilirubin, mg/dl
Glutamic oxaloacetic
transaminase, IU//
Lactic dehydrogenase,

15

iu n

Alkaline phosphatase,
IU//
Protein, g/dl
Albumin, g/dl
Amylase, Street and
Close units/dl
a-antitrypsin, mg/dl
a-fetoprotein, [xg/ml
Prothrombin time, s
Urine:
Bile
Urobilinogen, Ehrlich
units/dl
Sweat chloride, mmol//
Chest radiograph
Abdominal radiograph

I nvesti

8.7, normal differential
1.4
6.1; direct, 4.4
49
294
346
5.7
3.0
< 15
>420
<1.0
Patient, 14; control, 11.4
2+
0.1
22
Normal
Consistent with ascites
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Fig. 1.—Radioactive iodine (131I) rose-bengal
liver scan demonstrates normal uptake at 1V4
hours.

Fig. 2.—Extravasation of contrast medium from
distal end of cystic duct,

In the interval between admission and opera
tion the baby’s stool colour varied from pale
to light brown. A peritoneal tap yielded clear
yellow fluid, which was sterile. Liver scan
with 131I rose bengal showed normal up
take at 1Vi hours (Fig. 1) and diffuse activity
throughout the whole abdomen at 24 hours,
particularly along the paracolic gutters and in
the pelvis. Spontaneous rupture of the bile
ducts was considered likely. At operation, 800
ml of bile-stained fluid was removed. There
were extensive plastic adhesions between vis
cera. The liver was normal in size and texture
but was heavily bile-stained. Contrast medium
injected through a small polyethylene catheter
placed in the gallbladder revealed extravasation
of dye from the junction of the cystic and
common hepatic ducts (Fig. 2). Further dis
section confirmed the presence of a small
perforation (diameter, 1 to 2 mm) in the
anterior surface of the junction of the cystic
and the common hepatic ducts. No gallstones
were seen. Cholecystectomy was performed.
Choledochography done via a catheter through
the perforation demonstrated a normal extrahepatic biliary system (Fig. 3). The perforation
was oversewn with figure-of-eight chromic
4-0 catgut sutures. The baby made an un
eventful recovery. Pathologic study of the
distal end of the cystic duct revealed a well
demarcated area of necrosis, edema and con
gestion. In addition bile in the submucosa and
the subserosa was associated with pronounced
foreign-body reaction including many foam
cells. The inflammatory reaction was con

sistent with an on-going process of 4 to 6
weeks.
D iscussion

The clinical course of spontaneous per
foration of the bile ducts is usually subacute
with fluctuating obstructive jaundice. The
most important clinical feature is abdominal

Fig. 3.—Choledochogram demonstrates normal
extrahepatic biliary system.
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distension with bile ascites that, if mild, is
easily missed. The ascites is sometimes
recognized because of the presence of a
fluid-filled hernia, either umbilical or in
guinal. Occasionally in untreated or un
recognized cases acute symptoms of perito
nitis develop followed by cardiopulmonary
collapse and death. In the commoner sub
acute form, there is typically an elevated
concentration of serum bilirubin — mostly of
the direct type — associated with normal
liver function, lack of evidence of hemolysis,
and urine that contains bile and has a low
urobilinogen value.
The sites of perforation, in order of de
creasing frequency, are: junction of the
cystic and common hepatic duct, the com
mon hepatic duct, the common bile duct,
the gallbladder, and the junction of the
cystic duct and the gallbladder.
The cause of spontaneous perforation of
the bile ducts is unknown. A number of
factors have been held responsible: trauma,6
congenital abnormality,7 infection,2- 8 reflux
of pancreatic secretion,9 obstruction,2 cal
culi10- 11 and abnormal bile.12- 13 How
ever, the evidence for these factors was
mostly circumstantial. A history of trauma
was seldom elicited in the reported cases.
It is conceivable that minor trauma during
birth or neonatal life may exert enough
traction on the gallbladder through the
neonate’s weak abdominal wall to avulse
the cystic duct from the common hepatic
duct, which is the commonest site of per
foration. In this connection, the forceps
delivery used in our case might be relevant.
Compression of the gallbladder may cause
a sudden rise in intrabiliary pressure result
ing in a rupture, perhaps through a con
genital abnormality such as the locus minoris
resistentiae,7 or a rare small diverticulum.14
Infection is unlikely to be a primary
cause of spontaneous perforation of the bile
ducts because in the cases reported in the
literature there was rarely any clinical evi
dence of sepsis. In the few cases in which
infected bile was recovered, the infection
probably followed the perforation and was
secondary to the bile ascites. Similarly reflux
of pancreatic enzymes, as suggested by the
presence of fat necrosis around the perfora
tion, occurred too infrequently to be an
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important factor in the etiology of sponta
neous bile-duct perforation.
Congenital stenosis or stricture of the
bile ducts has been associated with perfora
tion, but a direct cause and effect relation
ship is difficult to substantiate. Most infants
with congenital biliary stenosis or stricture
do not have perforation. In the cases in
which obstruction from congenital narrow
ing or stricture was found near the perfora
tion, simple closure of the perforation was
often successful; this would be unlikely if
the obstruction had caused the perforation
in the first place.
Calculi and inspissated bile10'13 have
also been implicated in the etiology of bileduct perforation. However, the mere pres
ence of calculi or thick bile does not prove
a causal relationship. In the case reports of
infants with both biliary perforation and
calculi, the bile ducts were seldom dilated
and neither acute nor chronic inflammation
at the site of perforation was mentioned.
That abnormal bile may be deposited on
the wall of the bile ducts causing a local
chemical inflammatory process that weakens
the site for subsequent perforation cannot
be refuted. In our case, the microscopic
picture of localized necrosis, edema, con
gestion, bile deposition and foreign-body
inflammation is consistent with such a view.
However, we believe it more likely that the
inflammatory reaction was secondary to bile
leakage from the perforation, which prob
ably occurred during birth from minor
trauma.
Conclusions

The diagnosis of spontaneous perforation
of the bile ducts depends on an awareness
of the condition, especially if bile ascites is
present. Confirmatory investigations include
(a) intravenous cholangiography,15 which
is often successful despite the elevated
serum bilirubin concentration as the liver
function is usually unimpaired in the early
stage of the disease, and (b) mI rose-bengal
liver scan with a follow-up reading at 24
hours or measurement of the radioactive
tracer in the ascitic fluid obtained by aspira
tion.16 This will confirm leakage of bile
into the general abdominal cavity. The
treatment of spontaneous bile-duct perfora-
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tion is surgery. A variety of procedures
have been advocated: simple drainage
of the subhepatic space, drainage through
the perforation, closure of the perforation
with or without drainage, cholecystectomy
for perforation of the gallbladder, and some
form of biliary enteric anastomosis if a
stricture or stenosis is present. In the case
reported herein, removal of the gallbladder
and suture of the perforation were carried
out with an excellent result.
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EFFECT OF CURRENT PALLIATIVE TREATMENT ON THE
SURVIVAL OF PATIENTS WITH BREAST CANCER*
J. E. DEVITT, MD, FRCS(Edin), FRCS[C] and D. A. ADVENT1
The length of survival of 302 patients with
breast cancer, first treated between 1946 and
1949, who had mostly only contemporary radio
therapy for metastases, has been reviewed and
compared with that of 578 patients, first treated
between 1966 and 1969, who had modern endo
crine therapy, cancer chemotherapy and radia
tion therapy. Although patients in the latter
group demonstrated a significantly increased
length of survival after the first metastases ap
peared, these differences were not substantial.
In spite of impressive regressions in some pa
tients with metastatic breast cancer after
modern palliative therapy, the median survival
after the first appearance of metastases has
been increased only by about 6 months.
On a etudie la survie de 302 patientes souffrant
de cancer du sein, dont le traitement a ete institue entre 1946 et 1949, et pour qui, a cette
epoque, la radiotherapie constituait le seul recours contre les metastases, et on I'a comparee a celle de 678 patientes, dont le traitement
a commence entre 1966 et 1969 et qui ont eu
acces aux traitements endocriniens modernes,
a la chimiotherapie anticancereuse et a la radio
therapie. Bien que les patients de ce dernier
groupe aient montre des survies significativement prolongees apres I'apparition des premie
res metastases, ces differences n'ont pas ete
substantielles. En depit des regressions spectaculaires constatees apres un traitement palliatif moderne chez certaines patientes atteintes
de cancer du sein en metastase, la survie
moyenne apres I’apparition des premieres me
tastases n'a ete prolongee que d'environ 6
mois.

I t is uncertain whether the age-specific
mortality rates for breast cancer have
changed in the last 30 years,1' 2 in spite
of the notable improvement often seen after
endocrine or chemotherapy in patients with
metastatic breast cancer. Patients who re
spond to these forms of systemic therapy
*From the Civic Hospital division, Ottawa clinic,
Ontario Cancer Treatment & Research Founda
tion, and the department of surgery, Ottawa Civic
Hospital, University of Ottawa, Ottawa, Ont.
tMedical student.
Reprint requests to: Dr. J. E. Devitt, Director,
Continuing medical education, University of
Ottawa, Ottawa Civic Hospital, 1053 Carling Ave.,
Ottawa, Ont. K1Y 4E9.

often'live longer than those who do not.3 4
However, this observation may not result
so much from therapy as from the selection
of patients with favourable (i.e., responsive)
disease from among those with aggressive
disease.
We reviewed the survival of patients with
metastatic breast cancer who first were
treated for their primary disease in the pe
riods 1946 to 1949 and 1966 to 1969. The
patients in the latter period enjoyed the
advantages of current endocrine and chemo
therapy, whereas few, if any, of the patients
in the former period did. Thus, if current
palliative treatment lengthens survival, the
patients in the latter group should have
survived longer after their first metastases
appeared. Survival after the first appearance
of metastases was examined, since it seemed
likely that the time of recognition of first
metastases would be similar in the natural
history of both groups.
P atien ts and M ethods

The series comprised 302 patients who
first were treated for breast cancer in the
period 1946 to 1949 (group 1) and 578
patients in the period 1966 to 1969 (group
2). All patients reported to the Civic Hos
pital division of the Ottawa clinic of the
Ontario Cancer Treatment & Research
Foundation. The two groups were followed
until the end of 1955 and 1975 respectively.
Location and time of detection of the first
metastases were noted and survival was cal
culated from that time for patients who
underwent definitive breast surgery (277 in
group 1 and 544 in group 2). Those not
operated upon had advanced disease that
was treated by radiation or systemic therapy.
The length of pretreatment history, the
5-year survival rate, the regional recurrence
rate and the presenting stage were studied.
We grouped all patients retrospectively ac
cording to stage using the following criteria:
Stage 1.— The tumour measured, at
pathologic examination when possible, 5 cm
or less in diameter. There was no peau
d’orange, skin infiltration or ulceration,
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or chest-wall fixation, but skin dimpling or
tethering, nipple retraction or pectoral
muscle fixation did not exclude a patient
from this category. Edema of the arm was
absent. No supraclavicular lymph nodes
were palpable. Histologic examination did
not reveal axillary lymph-node metastases.
Stage 2.—The features of the primary
lesion were as in stage 1, but histologically
proven axillary lymph-node metastases were
present. If those nodes were palpable clin
ically, they were not fixed to each other or
to adjacent structures.
Stage 3.—The tumour was larger than
TABLE I.—P atient Aw are

of T umour B efo re
F irst T reatment

No. of patients (and %)
Time before
treatment,
mo

Group 2
(:n = 578)

Group 1
(n = 302)
55
75
62
40
61
9

1— 3
3 — 6
6 — 12
^ 12
Unknown

206
150
73
21
101
27

(18)
(25)
(21)
(13)
(20)
( 3)

(35)
(25)
(13)
( 4)
(17)
( 5)

TA B LE I I - - P roportion of P atients in E ach
C linical S tage

No. of patients (and %)
Group 1
(n = 302)

Stage

149
88
54
11

1
2
3
4

Group 2
(n = 578)

(49)
(29)
(18)
(4 )

267
176
114
21

(46)
(30)
(20)
( 4)

TA B LE III.—O utcome

5 cm in its greatest diameter or showed one
or more of the clinical signs described as
being absent in the first two stages.
Stage 4.—Distant metastases were known
to be present.
The chi-square test was used to test statis
tical significance for the data in Tables I
to III and the Mann-Whitney test for Table
IV.
O bservations

The interval between patient awareness
of the tumour and the time patients reported
for treatment differed in the two groups
(Table I); whereas in group 1 only 18%
reported in 1 month or less after noticing
their tumour, in group 2, 35% had such
a short history (P < 0.01). Whereas 33%
of group 1 patients had been aware of their
mass for 6 or more months, only 21% of
the group 2 patients had such a history
(P < 0.01).
There was no change in the proportion
of patients in the different clinical stages
(Table II).
There was a trend, not significant, for
5-year survival rates (P = 0.1) and local
control rates (P = 0.1) of those who under
went surgery to improve (Table III).
The length of survival after the first ap
pearance of metastases was longer for the
patients in group 2 and for patients whose
first metastases were lung/pleural, bons or
regional (Table IV). Though the differences
in survival time after the various types of
metastases first appeared were statistically
significant they were not substantial (only
6 mo).

% of patients (and no.)
Group 1

Outcome

5-yr survival
53 (159/302)
Regional recurrence 24 ( 66/277)

D iscussion

Group 2

The patients in group 2 had the advantage
of modern endocrine therapy and cancer
chemotherapy and radiation therapy. The

59 (342/478)
19 (102/544)

TABLE IV.—M edian S urvival A fter D etection
Group 1
Type of metastasis
All types.................................................
Lung/pleural..................................................
Bone.................................................................
Regional.........................................................

Months

5
7
13.5

F irst M etastases

Group 2

No. of
patients

10

of

141
41
45
60

Months

No. of
patients

P value

14
13
13
18.5

244
59
91
82

< 0 .0 1
< 0.01
< 0.01
< 0.05

The Effect of

Trasylol
* Results

Acute
Pancreatitis

Trasylol® was shown to reduce mortality in acute pancreatitis to a s ig n ific a n t«,
@xt6n t .
P la c e b o .................................................... 25.0% Mortality
Trasylol® ...................................................
7.5% Mortality
“ Because the number of deaths were reduced, the spectrum of the disease
as a whole was altered.” *
T rapn ell’s recent double-blind clinical trial
involving 105 patients confirm ed the
effectiveness of Trasylol in acute
pancreatitis. In addition to reducing
m ortality and altering the spectrum of the
disease, Trasylol largely abolished the usual
effect of increasing age in this condition.
Trasylol should be given concurrently with
usual measures for the treatm ent of
pancreatitis, such as pain relief,
fasting, gastric suction, etc. “ It
(Trasylol) can therefore now be
regarded as a drug w hich is both
effective and beneficial in the
treatm ent of acute pancreatitis.” *
*Trapnell, J.E. et al, British
J. Surg., March 1974.

The Effect of

Trasylol

in
Hyperfibrinolytic
Hemorrhages

S
k

■r

Trasylol, in its role as an
antifibrinolytic agent, inhibits
both plasmin and the
plasminogen activator.

Synthetic antifibrinolytic
agents inhibit only the
plasminogen activator,

Trasylol is indicated for primary and generalized, secondary
hyperfibrinolytic hem orrhages with and w ith o u t the shock
syndrome. Secondary hyperfibrinolysis follow ing
intravascular clotting may require heparin a n d /o r
fibrinogen replacement in addition to Trasylol.
With Trasylol, the an tifibrin olytic agent w ith
sim ultaneous anti-coagulant (anti-th rom bop lastic)
effect, there w ill not be a dangerous shift
in the equilibrium between
the clotting and the lysis system
in favo ur of coagulation.
Synthetic a n tifib rin o lytics
are contraindicated if there is
evidence of active intravascular
coagulation. Trasylol is indicated
in all cases of hyperfibrinolysis,
w hether a differential diagnosis
has been made or not.
FBA Pharmaceuticals Ltd.
Distributed by:
Boehringer Ingelheim (Canada) Ltd.
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• increases the chances
of survival in acute
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• prevents the enzymatic
release of toxic
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• stops hyperfibrinolytic
hemorrhage
Indications and Dosage
Hyperfibrinolytic Hemorrhage
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bleeding conditions, such as in abruptio
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Initial dosage: 200,000 — 500,000 K.I.U.
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by intravenous injection (a t a rate not to
exceed 5 ml per minute), the rest if neces
sary by slow in fu sio n . A d m in istra tio n
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K.I.U. per day until the hemorrhage has
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Pqn c tga titis
Initial dosage: 100,000 — 200,000 K.I.U.
to be follow ed by 100,000 K.I.U. every
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drug is adm inistered eith e r by intraven
ous injection (at a rate not to exceed 5
ml per minute) or by slow infusion.

Warnings and Precautions
Trasylol is a polypeptide and thus may
act as an antigen. Although adverse reac
tions due to hypersensitivity have been
described infrequently, th is possibility
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w ith a h is to ry o f h y p e rse n sitivity, the
usual precautions for the prevention and
a rre s t of a lle rg ic re a c tio n s should be
observed prio r to the adm inistration of
Trasylol.

Availability
Trasylol (aprotinin) is available in 10 ml
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boxes of 5 ampuls.
Trasylol® P roduct Monograph is available
on request.
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B o e h rin g e r Ingelheim (C a n a d a ) Ltd.
2121 T ra n s C a n a d a H ighw ay, D o rval, P.Q. H 9 P 1J3
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patients in group 1 had only radiotherapy
available for metastatic disease. To assess
the effect of the modern therapies we studied
the length of survival after the first metastases were noted. This starting point was
used to avoid the increase in survival that
can result from earlier counting. Indeed a
trend to improvement in the 5-year survival
rates was noted but was not significant. In
group 2 the duration of symptoms was
shorter though the distribution of presenting
clinical stages was unchanged. It seemed
likely that the time in the natural history
of recognition of first metastases should be
similar over the 20 years. The symptoms
of metastases should have been no different
in both groups.
In spite of the dramatic regressions that
some patients in group 2 enjoyed, the dif
ferences in survival time between the two
groups of patients after appearance of first
metastases, though significant, were not sul>
stantial. Presumably the regressions were
sufficiently few, and of sufficiently short
duration, that median survival times were
lengthened by only approximately 6 months.
This would not alter age-specific mortality
rates.
C

o n c lu s io n

Current palliative therapy for breast
cancer, though producing individual impres
sive regressions, has produced only limited
increases in median survival after the first
appearance of metastases. This would ac
count for the failure of these therapies to
improve age-specific survival rates.
We thank Dr. R. C. Nair of the department
of epidemiology and community medicine of the
University of Ottawa for his kind assistance and
advice with the statistical analyses.
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AIR EMBOLISM WITH NEUROLOGIC COMPLICATIONS:
A POTENTIAL HAZARD OF CENTRAL VENOUS CATHETERS*
D. M. GRACE, M D, FRCS[C]

In two patients air embolism caused by discon
nection of subclavian venous catheters resulted
in cerebral damage. Both patients were receiving
long-term parenteral nutrition; both were in an
upright position and were slightly dehydrated
at the time the embolism occurred. The occur
rence of air embolism during the insertion of
central venous or subclavian catheters is well
known, but the development of this complica
tion in patients in whom the intravenous line
becomes disconnected has not been stressed.
It is important to recognize and treat the con
dition promptly. Also important in the preven
tion of this condition is catheterization in pa
tients who are properly hydrated and who are
in the Trendelenburg position, and care of the
catheter thereafter.
Chez deux patientes, une embolie gazeuse causee
par la disjonction d'un catheter veineux sous-clavier a entraine des dommages cerebraux. Les
deux patientes etaient sous nutrition parenterale
au long cours; les deux etaient en position verticale et legerement deshydrates au moment oil
I'embolie est survenue. L'apparition d'une embolie
gazeuse au moment de I'insertion d'un catheter
veineux central ou sous-clavier est un fait bien
connu mais on n'a pas souligne le developpement de cette complication avec la disjonction
d'une tubulure intraveineuse. II est important
de reconnaitre et de corriger rapidement
cette complication. II est aussi important de la
prevenir en procedant au catheterisme chez des
patients bien hydrates et places dans la posi
tion de Trendelenburg, et le catheter doit faire
I'objet d'une attention particuliere par la suite.
I n s e r t io n of catheters into the subclavian
vein and more centrally is now common on
surgical wards as a preliminary to parenteral
nutrition; it has even been recommended as
a routine procedure before operation.1
Subclavian or central venous catheterization
may, however, be complicated by the oc
currence of air embolism. This may occur
not only during insertion of the catheter
but also if the catheter inadvertently be*From the department of surgery, University of
Western Ontario and University Hospital, London,
Ont.
Reprint requests to: Dr. D. M. Grace, Department
of surgery, University Hospital, 339 Windermere
Rd., London, Ont. N 6A 5A5.

comes disconnected during infusion, espe
cially if the patient is upright. This com
plication may not be generally recognized.
In this paper we report two cases of cere
bral damage resulting from air embolism
associated with long-term parenteral nutri
tion by subclavian catheterization, and we
emphasize the diagnosis and prevention of
the complication.
C ase R e p o r t s

Case 1.—A 52-year-old woman had been
treated by irradiation of the sacrum for recur
rent carcinoma of the colon. Subsequently
severe radiation enteritis and small-bowel ob
struction developed. Operation for obstruction
at another centre was followed by a highoutput jejunal fistula with major skin break
down. After transfer to our hospital she re
ceived local wound care and drainage, and
parenteral nutrition through a subclavian cath
eter was started. After 3 months of hyper
alimentation the skin had healed but the fistula
persisted. Glucosuria resulting from intoler
ance of the glucose load was treated by re
striction of glucose and amino acids and
administration of insulin for several days. One
morning, while the patient was standing, the
intravenous line inadvertently became discon
nected; she immediately collapsed and became
comatose. Respiration was depressed and she
was hypotensive. Cardiopulmonary resuscita
tion was started. She was placed in the left
lateral decubitus position with the feet elevated
but remained comatose. One hour later re
sponse to painful stimuli returned but she had
a left flaccid hemiparesis. By the next day her
leg had recovered but the left arm remained
paralyzed. After several days she regained
some strength in the left upper arm but weak
ness of the left hand and loss of finger exten
sion persisted until her death 8 months later.
Careful assessment by neurologists revealed no
other cause for the neurologic change; they
considered the findings to be consistent with
air embolism. Hyperalimentation was con
tinued with the line securely taped in position.
The small-bowel fistula was later repaired by
operation.
Case 2.—A 58-year-old woman was treated
by parenteral nutrition through a subclavian
catheter because of severe diarrhea and
weight loss (16 kg) after extensive resection
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of gangrenous small bowel 2 months earlier
in another hospital. She had a history of vas
cular disease, and a right femoropopliteal by
pass graft had been carried out several years
before.
Radiographs showed about 60 cm of small
bowel remaining and severe stricture of the
terminal ileum. After 2 weeks of hyperalimen
tation the stricture in the ileum was resected
and the remaining jejunum implanted into the
ascending colon. Two days later, while she was
standing, her subclavian line was noted to be dis
connected. She complained of weakness, then
quickly collapsed and became comatose. Res
pirations were depressed. She was immediately
placed in the Trendelenburg position. Con
sciousness returned over the next hour but
her left side was paralyzed and a left Babinski
sign was noted. Use of her left arm and leg
returned over the next few hours and 24 hours
later all neurologic abnormalities had disap
peared. Her recovery was uncomplicated.
D iscussion

For many years a distinction has been
made between arterial and venous air em
bolism. Tiny amounts of arterial air may
have lethal effects while large amounts of
venous air may be tolerated.- The causes of
air embolism are many. Open-heart surgery
is one cause of arterial air embolism while
venous air embolism has occurred through
dural sinuses or major neck veins during
head and neck operations, especially with
the patient in the sitting position. Other
causes of venous air embolism are pneumo
peritoneum,3 intravenous infusion under
pressure, perirenal air injection, pneumo
peritoneum and placenta previa.- Recently
added to the list is the central venous cath
eter.4' 8 The volume of air that may pass
through such catheters in a short time is
surprisingly great'-’ and may be lethal.4- 7- 8
Though it has been recognized for some
time4- 7 that air embolism may occur during
insertion of subclavian catheters it has not
been emphasized that this complication may
occur if the line disconnects, especially if
the patient is upright or is dehydrated,3- 8- 9
as illustrated in our two patients. Both were
slightly dehydrated when the air embolism
occurred. One had glucosuria and the rate
of infusion of glucose and amino acids was
reduced for 24 hours. The second had un
dergone major abdominal surgery several
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days before. Both patients were standing
when the subclavian lines disconnected. In
the absence of the classical “millwheel”
murmur one might question whether some
other event led to collapse and neuro
logic change. However, disconnection of
intravenous tubing and subclavian catheter
in two patients who were lucid and active
was followed immediately by collapse and
dense coma. The pattern of subsequent
neurologic change was the same in each
patient and it is therefore hard to avoid
the conclusion of cause and effect.
In any patient with a subclavian or central
venous catheter sudden cardiovascular col
lapse should be considered to be caused by
an air embolism,9 even though pulmonary
embolism or myocardial infarction are more
common possibilities. A classical “millwheel” murmur confirms the diagnosis but
is often absent.10 The mechanism of death
seems to be an outflow obstruction of the
right ventricle.- The left lateral decubitus
position with the right side up is helpful
because the outflow tract is then below the
air and the air lock is apparently relieved.
The Trendelenburg position improves venous
return, elevates central venous pressure and
distends subclavian veins; this makes inser
tion of a subclavian line easier and helps
prevent air embolism. In one case reported
by Ordway9 the Trendelenburg position
was necessary for days.
Cerebral air embolism may occur with
small amounts of arterial air, especially if
the head is higher than the heart, and may
not be fatal.2 Air may traverse a patent
foramen ovale when outflow obstruction of
the right side of the heart leads to very
high pressures.1" Air may also traverse
the pulmonary vascular bed by unknown
means, and air has been observed in cere
bral vessels during neurosurgical procedures
on patients in the sitting position.10 In the
patients described in this paper it is not
clear if the neurologic change was due di
rectly to cerebral air embolism or whether
the hypotension alone, caused by venous
air embolism, was sufficient.
Prevention
Since treatment of established air em
bolism is unsatisfactory, prevention must be
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Pulmonary (venous) air embolism. Am
stressed. Routine use of subclavian lines is
Heart J 33: 269, 1947
not recommended. Proper hydration when 3. M usgrove
JE, M acQ uigg RE: Successful
treatment of air embolism. JAMA 150: 28,
possible before insertion of such catheters
1952
and use of the Trendelenburg position dur
JP, G radisar 1A, G ross RJ, et al:
ing insertion are important. The intravenous 4. F lanagan
Air embolus — lethal complication of sub
clavian venipuncture. N Engl J Med 281:
line and subclavian catheter must be tightly
488, 1969
connected and taped in position, especially 5. H oshal
VL, F ink GH: Subclavian catheter
if the patient is active. The line may still
(C). Ibid, p 1425
CL, Lazarchick J, L ynn HB: Sub
become disconnected under a dressing and 6. J ohnson
clavian venipuncture: preventable complica
any wet or bloody stain on the dressing
tions; report of two cases. Mayo Clin Proc
45: 712, 1970
should be investigated. A lock connection
W J: Fatal air embolism during
between subclavian catheter and intravenous 7. L evinsky
insertion of CVP monitoring apparatus.
line may be useful although those that we
JAMA 209: 1721, 1969
CE, I rani F: Air embolus via sub
have tried so far have not been effective. 8. Lucas
clavian catheter. N Engl J Med 281: 966,
If air embolism does occur the Durant or
1969
left lateral decubitus position is best; the 9. Ordway CB: Air embolus via CVP catheter
without positive pressure: presentation of
steep Trendelenburg position may also be
case and review. Ann Surg 179: 479, 1974
helpful. These may reduce mortality greatly. 10. H amby
WB, T erry RN: Air embolism in
operations done in sitting position; report
Attempts have been made to aspirate air
of five fatal cases and one of rescue by
from the heart in cases of established air
simple maneuver. Surgery 31: 212, 1952
embolism but this method is not reliable. 11 11. Sink ID, C omer PB, J ames PM, et al: Evalu
ation of catheter placement in treatment of
For cerebral air embolism during cardiac
venous air embolism. Ann Surg 183: 58,
surgery a compression chamber and hyper
1976
baric oxygen have been recommended and 12. K indwall EP: Massive surgical air embolism
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used with some success.12'1'’
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Aerospace Med 44: 663, 1973
H, Olszewski W, Schimert G, et al:
with central venous catheters and hyper 13. T akita
Hyperbaric treatment of cerebral air em
tonic glucose we now use Intralipid and
bolism as result of open-heart surgery:
report of case. J Thorac Cardiovasc Surg
amino acids by a peripheral route when
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bolism and cerebral edema: one regimen
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BONE LESIONS IN EARLY SYPHILIS
Destructive bone disease is a well known com
plication of tertiary syphilis. Dismukes and col
leagues (JAMA 236: 2646, 1976) remind us that
destructive bone lesions, though rare, may be a
complication of early syphilis; they report a pa
tient with secondary syphilis whose findings in
cluded generalized lymphadenopathy, perianal
condylomata and a maculopapular rash over the
palms, soles and forearms. Laboratory investiga
tion confirmed the diagnosis of syphilis. The pa
tient complained of headache, and pain in the
right shoulder and anterior chest. A swelling was
noted over the right anterior chest. Osteolytic
bone lesions were found on radiographic examina
tion; syphilitic osteomyelitis was suspected and
later confirmed with a tissue diagnosis. Reynolds

and Wasserman (Arch Intern Med 69: 263, 1942)
reported only 15 cases of bone involvement among
the 10 000 patients they reported with early in
fectious syphilis. The skull is most frequently
affected; headache is the usual clinical symptom
and is often so severe that acute syphilitic menin
gitis may be considered in the differential diag
nosis. Bony swellings may be seen. Involvement of
skeletal structures may precede the mucocutaneous
lesions of secondary syphilis or may be the only
manifestation. Finally, the osteolytic manifestations
of early syphilis cannot be differentiated radio
graphically from those due to bacterial or tuber
culous osteomyelitis, multiple myeloma and car
cinomatous metastases.
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ANGIOGRAPHY: AN ESSENTIAL DIAGNOSTIC AID IN
ASYMPTOMATIC AORTIC ANEURYSM?
ROBERT CYR, MD,* JULES TRUDEL, MD, FRCS[C],t
ANTOINE G. RABBAT, MD, FRCP[C],t JACQUES TRUDEL, MD, FRCP[C],t
MICHEL LAFORTUNE, MD, FRCP[C]§ and GUY G. LEMIRE, MD, FRCS[C]1I
Aortography is a highly desirable diagnostic
procedure for evaluating clinically diagnosed
abdominal aortic aneurysm. In a retrospective
study of 83 patients with such aneurysms, rou
tine angiographic investigation changed the
course of management in 17. The morbidity as
sociated with angiography in the investigation
of abdominal aortic aneurysm has been minimal.
In this situation angiography provides more in
formation than ultrasonography and therefore
should be used routinely.
L'aortographie est une procede de diagnostic
fort interessant pour revaluation d'un anevrisme
de I'aorte abdominale diagnostique cliniquement.
Dans une etude retrospective de 83 patients
souffrant d'un tel anevrisme, I'examen angiographique systematique a modifie ie traitement
chez 17 sujets. La morbidity associee a I’angiographie employee dans revaluation de I'anevrisme de I’aorte abdominale a ete minime.
Dans une telle situation, I'angiographie procure
plus d'information que I'ultrasonographie et devrait done etre utilisee de facon systematique.

A ortography is performed reluctantly in
patients with clinically detected abdominal
aortic aneurysm (AAA),1 because most
surgeons believe it is neither safe nor essen
tial. 2 In this paper we review our experience
with routine use of aortography to investigate
asymptomatic AAA in the light of the ad
vances in noninvasive ultrasound techniques.

and Dec. 31, 1975, with a clinical diagnosis
of AAA. Translumbar puncture was not
used, and routine ultrasonography was used
in the last year of the study only. The aver
age age of the patients was 66.4 years. They
were divided into two groups depending on
the results of aortography. Group 1 com
prised 46 patients (average age, 62.8 yr)
who underwent operation. Group 2 com
prised 37 patients (average age, 67.1 yr)
who were not operated upon.
R esu lts

Angiography was uncomplicated in 82 of
the 83 patients; in one patient a distal arte
rial block caused transient ischemia of the
great toe. There were no deaths attributable
to the angiography and no procedure caused
dissection of the aneurysm. In no patient
was an operation, scheduled as an elective
procedure, performed as an emergency
because of angiography. In one patient the
catheter was passed through a long mural
thrombus without any harmful effect (Fig.
1 ).

Group 1.— The procedures, in addition

P a tien ts and M ethods

Transfemoral or, occasionally, transaxillary aortography was performed in 83 pa
tients, hospitalized between Jan. 1, 1967
■Resident in surgery, University of Montreal,
Montreal, PQ.
tDepartment of surgery, St-Luc Hospital, Mont
real.
t Department of medicine, St-Luc Hospital.
§Department of radiology, St-Luc Hospital.
1[Department of surgery, University Hospital,
Saskatoon, Sask.
Reprint requests to: Dr. G. G. Lemire, Depart
ment of surgery, University Hospital, Saskatoon,
Sask. S7N 0W8.

Fig. 1.—Uncomplicated catheter
through long mural thrombus.

dissection
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TABLE I.—G roup 2. R easons

for

D eferring

Operation
Reason

Secondary to angiographic
fingings................................
Poor run-off.....................
Multilevel atherosclerosis.
Polyaneurysmal disease . .
No aneurysm (C-shaped
aorta)............................
Secondary to other causes. . . .
Medical contraindications
Refusal of treatment........
Cause unknown (chart
unclear)........................
Awaiting surgery.............

No. of patients

3
2
2
1

8

29

24
2
2
1

to a bypass operation (bifemoral, 37; biiliac 9), included renal artery revasculariza
tion (10 aortorenal bypasses) in seven pa
tients, release of a left renal artery kink in
one patient and closure of a renal arterio
venous fistula, 20 years after nephrectomy,
in another. Three patients died within 30
days (mortality, 6.5%); the deaths were due
to multiorgan failure, disseminated intra
vascular coagulation and suprarenal intradiaphragmatic aortic rupture.
Group 2 .— In 29 of the 37 patients opera
tion was postponed for a variety of medical
and other reasons (Table I). In eight patients
operation was postponed as a result of aortographic findings (Table I); seven patients
had a vascular contraindication, and one
was considered from the aortogram to have
an elongated C-shaped abdominal aorta,
mistaken for an aneurysm clinically and on
echography (Fig. 2).

Fig. 2.—Dilated C-shaped aorta mistaken clinic
ally for abdominal aortic aneurysm.
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D iscussion

The morbidity and mortality associated
with the surgical treatment of AAA is re
lated to concomitant atheromatous disease
or ischemia, or both, and is caused by the
corrective surgical procedure. Angiography
demonstrates the extent of atheromatous
disease and, more than any other diagnostic
aid, has led to advances in the surgical treat
ment of atherosclerotic disease.3 In experi
enced hands, angiography is a low-risk
diagnostic procedure, as is borne out by our
data. Ultrasonography has added another
dimension to the investigation of AAA but
provides only a morphologic picture of the
lesion — the outer-inner dimension of the
aneurysmal formation and its potential or
existing dissecting tendency.4 It fails to give
accurate detail of the position of the renal
arteries in relation to the aneurysm, or of
the emerging visceral trunks.
The benefits derived from angiography
in our series are apparent — the data ob
tained in the operated cases led to renal
artery surgery in 9 of 46 operated cases and
operation was deferred in 8 of 83 cases
because of the angiographic findings. In
eight patients angiography called attention
to critical renal artery stenosis. Aortic re
construction with concomitant aortorenal
bypass was done with the primary intent of
protecting renal parenchyma. The theoret
ical advantage of preventing malignant
hypertension in acute renal ischemia consti
tutes a remote reason.5 Angiography also
demonstrated a renal arteriovenous aneu
rysm in one patient. Furthermore, angiogra
phic findings precluded operation in seven
patients with vascular complications and
one with an elongated C-shaped aorta, mis
taken for an aneurysm. Thus, the manage
ment of AAA was modified in over 20%
of the total group (17 of 83) while the
complication rate due to angiography was
kept extremely low (1.1%), well worth the
price considering the crucial information
obtained.
As Robicsek and colleagues6 pointed out,
the surgeon can only be thankful that addi
tional information such as the presence of
polar renal arteries, aortocaval fistulas, un
suspected arcades of Riolan, saccular aneu
rysms and retroperitoneal leaks may be
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TEACHING OF BASIC SCIENCES IN POSTGRADUATE SURGERY*
JEAN G. COUTURE, MD, FACS, FRCSfC]

In this paper, important deficiencies in the
teaching of basic sciences to residents under
going training in the surgical specialties are
underlined.
Since the Royal College of Physicians and
Surgeons of Canada has stipulated that resi
dents must be successful at an examination in
basic sciences before being admitted to the final
examination in certain surgical specialties, it is
important that program directors plan the
organization of an adequate program in this
area.
To achieve this goal, it is suggested that
closer cooperation is needed between the basic
sciences and clinical departments of our medical
schools so that specific objectives may be de
fined and teaching of basic sciences become
more consistent with the prerequisites put
forward by the Royal College.
Dans ce travail, I'auteur souligne d’importantes
lacunes dans I'enseignement des sciences fondamentales aux residents inscrits a des program
mes de formation dans des disciplines chirurgicales.
Etant donne que le College Royal des medecins et chirurgiens du Canada demande a ces
etudiants de reussir un examen en sciences
fondamentales avant de se presenter aux examens terminaux dans certaines specialites chi-

*Presented at the meeting of the Canadian Asso
ciation of Clinical Surgeons, Quebec City, PQ,
Mar. 18, 1975.
Reprint requests to: Dr. J. G. Couture, Depart
ment of surgery, Hopital du Saint-Sacrement, 1050
Chemin Ste-Foy, Quebec, PQ G1S 4L8.

rurgicales, il importe que les directeurs des
programmes universitaires prevoient ('organisa
tion d’un programme adequat dans ce domaine.
Pour atteindre cet objectif, I’auteur est d'avis
qu'une plus grande collaboration devrait exister
entre les departements de sciences fondamen
tales et cliniques des facultes de medecine afin
de definir des objectifs specifiques permettant
de dispenser un enseignement plus conforme
aux prerequis proposes par le College Royal.

The teaching of basic sciences at both the
undergraduate and postgraduate level gives
rise to some confusion, even among medical
educators, because of differences in content
and method.
Thus, in the curricula of some medical
schools, basic sciences include all aspects of
human biology; in those of others, the basic
sciences include biochemistry, physiology
and cellular biology; and in still other medi
cal schools, pharmacology, pathology and
immunology constitute the important com
ponents of the curriculum in basic sciences.
Similarly, the term “basic surgery” leads to
confusion: in some instances it means the
subject matter (e.g., shock or fluid balance),
while in others the term refers to the 1- or
2-year period during which the surgical
resident is exposed to problems related to
basic sciences. In general, however, basic
surgery corresponds to that part of the core
training related to the basic sciences.
It therefore is worth considering briefly
the ways in which basic sciences are taught
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to undergraduate and postgraduate students.
D e f ic ie n c ie s in t h e T eaching
o f B asic S cien ces

In general, during a surgical residency
knowledge of basic sciences is acquired by
one of two methods — through permeation
and through a more formal approach. The
nature of the permeation method is reflected
in the words of Hanlon,1 who has defined
the nature of basic surgery as “a series of
concepts underlying and permeating the daily
surgical activities of the candidate”. In his
opinion, the basic experience may precede,
follow or accompany exposure to specialty
activities. Since knowledge acquired by this
method is related to the capacity of a teacher
to transmit it to his students, there is doubt
about the degree of efficiency of such a
method. With the more formal approach, a
resident, according to some general sur
geons and members of surgical disciplines,
should be temporarily relieved of his
surgical duties and be assigned for a period
of time to formal study of basic sciences,
either in the laboratory or by attending a
course of lectures covering appropriate sub
jects.
Although many program directors think
that residents learn basic sciences through
permeation or osmosis, neither of these
methods has proven satisfactory. In fact,
most residents rely more on their personal
efforts and studies than on any other sug
gested method.
The American College of Surgeons and
the Royal College of Physicians and Sur
geons of Canada have proposed that basic
education in surgery for the first 2 years
be common to all surgical disciplines. After
this period, definitive training can be ac
quired for the next 2 or 3 years under the
responsibility of the directors in the various
specialties. However, neither the American
College of Surgeons nor the Royal College
has defined any specific objectives to help
program directors in preparing a basic scien
ce program in the first 2 years. The basic
surgical program, as proposed by the Royal
College, consists of a list of subjects that
residents are expected to study in prepara
tion for the basic surgical examination after
2 years of training. However, this program
is of a general nature and gives the residents
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limited help in the preparation for the exami
nation. This is exemplified by the following
two topics chosen from the basic surgical
program of the Royal College:
1. Bleeding, clotting and administration
of blood
Systems of coagulation and role of
various factors in intrinsic and ex
trinsic systems
Common causes of coagulation defects
Transfusions of blood and blood prod
ucts
2. Shock
Definition
Types
Methods of defining treatment
Secondary changes in shock
Treatment.
These two subjects, like all subjects that
constitute the basic surgical program, are
not fully defined and cannot be measured
in a specific way.
At the same time the Royal College re
quires evidence from the teaching centres
that a basic surgical program has been or
ganized and that the teaching of basic
sciences is satisfactory. This is clearly ex
pressed in the general guidelines that the
Royal College sets for itself in evaluating
specialty training programs. One stated ob
jective is “to review the scope, objectives
and content of the training programme in
cluding the arrangements made for the
teaching of the basic sciences of the special
ty in the faculty as well as in the teaching
hospitals”. Surveys of the teaching institu
tions by the Royal College and the Cor
poration Professionnelle des Medecins du
Quebec has not shown satisfactory evidence
of arrangements made for the teaching of
basic sciences. Presently most postgraduate
surgical programs include a prearranged
time span of 3 to 24 months in which the
resident is assigned to various nonclinical
departments including the animal research
laboratory, and the surgical pathology de
partment or the anatomy department, or
both. Teaching is accomplished by personal
involvement in the activities of these depart
ments and in a more formal way through
attendance at weekly seminars and lectures.
Learning should be accomplished in part
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through osmosis in these various milieux
and in part from the personal program
developed by the candidate to complement
his experiences. Clearly the teaching of
basic sciences is currently superficial and
not very specific.
There is a need for an integrated basic
sciences program. Many factors justify the
organization of such a program (e.g., basic
medical sciences are presented in an abbre
viated form; orientation of students is done
early and many change their minds; to fulfil
the requirements of the Royal College basic
surgical examination; to avoid duplication
such as discussion of the same topics in
many programs); one of the most important
factors is the poor integration of basic
sciences into clinical medicine in most medi
cal schools. After the first 2 years of under
graduate training, the medical student is
given very little training in the basic sciences
before his 1st year of residency. This lack
of continuity throws a strain on residents,
who are faced with a basic surgical examina
tion after 2 years of training.
It is therefore imperative that staff of
basic sciences departments of Canadian
medical schools realize how important is
their participation in the training program
not only at the undergraduate level, but also
at the postgraduate level. The integration
of scientists into the clinical departments is
necessary to ensure a “continuum” from the
1st year of medical school to the last year
of a residency program.
TABLE I.— R equirements

for

an

Integrated

B asic Sciences P rogram
Definition of
measured

specific

objectives

that can

be

Large faculty competent in many diverse sciences
Pedagogic activities that will realize objectives:
e.g., surgical anatomy, rotations in pathology,
research laboratory, formal lectures
Part of program to be multidisciplinary
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such a program are outlined in Table I.
Specific objectives in basic sciences should
be defined and should cover all aspects of
basic sciences knowledge at the under
graduate and postgraduate levels. This, of
course, would be more difficult at the post
graduate level, especially in surgery;
surgeons are by nature individualists,
not particularly receptive to the group
effort required to bring better basic
science
training into
surgical
post
graduate programs. An experiment carried
out at Wayne State University2 proved that
the best method of achieving this goal is
to assign the job to a team composed of one
surgical subspecialist and one specialist in
medical education. This kind of cooperative
effort will help program directors define
specific objectives for basic science educa
tion in most of the surgical disciplines.
In summary, the following comments can
be made concerning the teaching of basic
sciences to residents in general surgery and
other surgical disciplines:
1. In most medical schools a lack of
continuity in the teaching of basic sciences
from the undergraduate to the postgraduate
level explains in part the inadequate prepara
tion of residents for a surgical training
program.
2. Residency programs in surgery con
tribute little to the teaching of basic sciences
and, as such, provide limited assistance to
residents who are expected to pass the
basic surgical examination of the Royal
College.
3. While the need for an integrated
basic sciences program is stressed, it is also
acknowledged that such a program will re
quire the definition of specific objectives in
every surgical discipline and, as a conse
quence, will bring about a closer coopera
tion between the basic science and clinical
departments of Canadian medical institu
tions.

In-training evaluation procedures
R eferences

A R ecommendation
What then should be done in order to
make effective a completely integrated basic
sciences program? The requirements for

1. H anlon CR: Advantages and disadvantages
o f program for basic surgical education.
Ann Surg 168 : 579, 1968
2. R osenberg IK, Scott N C , S tahl A: Defining
core curriculum in surgery. Br J M ed Educ
6: 150, 1972
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PROGNOSTIC USE OF PREOPERATIVE AND IMMEDIATE
POSTOPERATIVE CARCINOEMBRYONIC ANTIGEN
DETERMINATIONS IN COLONIC CANCER*
J. H. OH, MD, PhD and L.D. MacLEAN, MD, FRCS[C]
Preoperative and postoperative carcinoembryonic
antigen (CEA) concentrations are useful in
predicting the likelihood of recurrence in pa
tients undergoing curative operations for cancer
of the colon. The incidence of recurrence was
studied in three groups of patients followed for
6 to 18 months after such an operation: 36
patients (group 1) had preoperative and post
operative plasma CEA concentrations less than
2.5 ng/ml; 11 patients (group 2) had a preoper
ative CEA value above but a postoperative value
below 2.5 ng/ml; and 11 patients (group 3) had
preoperative and postoperative concentrations
greater than 2.5 ng/ml. Cumulative rates of
recurrence at 6, 12 and 18 months after operation
were as follows: 0, 3 and 1 7 % in group 1; 0, 9
and 2 1 % in group 2; and 27, 79 and 7 9% in group
3. Statistically there was no difference in the re
currence rate between groups 1 and 2, but the
rate was significantly lower in group 2 com
pared with group 3. The data show that patients
in whom the immediate postoperative C EA con
centration returns to normal have a much lower
incidence of recurrent cancer of the colon than
patients whose CEA concentration remains
elevated.
Les concentrations pre- et postoperatoires
d'antigene carcino-embryonaire (ACE) sont uti
les pour predire la probabilite de recidive chez
les patients qui subissent une operation a but
curatif pour cancer du colon. L’incidence des
recidives a ete etudiee chez trois groupes de
patients qui ont ete observes pendant 6 a 18
mois apres I'operation: 36 patients (groupe 1)
avaient des concentrations plasmatiques pre- et
postoperatoires d'AC E de moins de 2.5 ng/ml;
11 patients (groupe 2) avaient une concentra
tion preoperatoire superieure mais une valeur
postoperatoire inferieure a 2.5 ng/ml; 11 pa
tients (groupe 3) avaient des concentrations
pre- et postoperatoires superieures a 2.5 ng/ml.
*From the department of surgery, Royal Victoria
Hospital and McGill University, Montreal, PQ.
Presented at the annual meeting of the Canadian
Society for Clinical Investigation, Toronto, Ont.,
Jan. 26, 1977.
Supported by a grant from the Medical Research
Council of Canada.
Reprint requests to: Dr. J. H. Oh, Surgical wing
(6W), Royal Victoria Hospital, 687 Pine Ave. W,
Montreal, PQ H 3A 1A1.

Les taux cumulatifs de recidive, 6, 12 et 18
mois apres I’operation ont ete comme suit:
0, 3 et 1 7% dans le groupe 1; 0, 9 et 2 1 % dans
le groupe 2; et 27, 79 et 7 9 % dans le groupe 3.
Statistiquement, il n’y avait aucune difference
entre les taux de recidive des groupes 1 et 2,
mais le taux etait significativement plus bas
dans le groupe 2 par rapport au groupe 3. Ces
donnees demontrent que les patients dont les
concentrations postoperatoires d'AC E retournent a la normale, ont une incidence beaucoup
moins elevee de recidive du cancer du colon
que les patients dont les concentrations d'AC E
demeurent elevees.
T h e demonstration of carcinoembryonic an
tigen (CEA) in cancer of the colon by Gold
and Freedman1 2 and description of a
radioimmunoassay for circulating CEA by
Thomson and associates3 have stimulated
many clinical studies for diagnostic and
prognostic purposes. Preoperative CEA
positivity (concentration, > 2.5 ng/ml) has
been reported to range from 59 to 97%
in patients with proven cancer of the
colon,3’6 and a gross correlation has been
noted between the CEA concentration and
the extent of the lesion.5’8 In postoperative
follow-up, serial CEA determinations have
proved useful in identifying patients in
whom recurrence developed.3’10
In this paper we assess the prognostic
value of preoperative and immediate (1 to
2 wk) postoperative CEA concentrations in
relation to cancer recurrence following cura
tive surgery.

Patients

and

M ethods

In 58 patients with resectable colonic can
cer, plasma CEA concentrations were de
termined before and 1 to 2 weeks after
operation. The patients were divided into
three groups depending on their preoperative
and immediate postoperative CEA concen
trations (without reference to the pathologic
stage of the disease) as follows: group 1 (36
patients), both preoperative and postopera
tive CEA concentrations of less than 2.5
ng/ml; group 2 (11 patients), CEA value
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TABLE I —I ncidence

of
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C ancer R ecurrence

Follow-up,
mo

N o. o f patients
at risk

N o. o f
recurrences

1 .................................. ............

0 — 6
6 — 12
12 — 18

36
35
28

0
1
4

0
3
17

2 .................................. ............

0 — 6
6 — 12
12 — 18

11
11
8

0
1
1

0
9
21

3 .................................. ..........

0 — 6
6 — 12
12 — 18

11
7
1

3
5
0

27
79
79

Group

C um ulative
recurrence, %

R e su l t s

Recurrence Rates

Fig. 1—Recurrence rates of colonic cancer after
curative surgery (group 1 preoperative and post
operative CEA values < 2.5 ng/ml; group 2 pre
operative value > 2.5 ng/ml, postoperative value
< 2.5 ng/ml; group 3 preoperative and post
operative values > 2.5 ng/ml.)

greater than 2.5 ng/ml preoperatively and
less than 2.5 ng/ml postoperatively; and
group 3 (11 patients), preoperative and post
operative CEA values greater than 2.5 ng/ml.
Follow-up in each patient was from 6 to 18
months postoperatively; cancer recurrence
was assessed by periodic clinical assessment,
operative and autopsy findings, as well as
CEA determinations.
Plasma CEA concentration was measured
by the radioimmunoassay technique of Elansen and colleagues.11
The rates of recurrent cancer of the colon
were calculated at 6, 12 and 18 months
after operation by life-table analysis.12 Stat
istical comparison of the recurrence rates
was carried out by the chi-square technique.
We also compared the preoperative CEA
values of groups 2 and 3.

Cumulative rates of cancer recurrence for
each group at 6, 12 and 18 months post
operatively are set forth in Table I and
Fig. 1.
Comparison of recurrence rate in groups
1 and 2.—Kates of recurrence were com
pared first between groups 1 and 2, both
having a postoperative CEA concentration
less than 2.5 ng/ml. Expected frequencies
of recurrence were calculated from the num
bers related to the two groups in Table I.
The overall comparison is shown in Table
II. Chi-square analysis revealed no signifi
cant difference in cancer recurrence between
the two groups (P > 0.70).
Comparison of recurrence rate in groups
2 and 3.—Rate of cancer recurrence in
group 2 was then compared with that of
group 3, since the postoperative CEA con
centrations remained elevated in group 3
only. Expected frequencies of recurrence
were similarly calculated from the numbers
related to the two groups in Table I, and
the overall comparison is shown in Table
II. Chi-square analysis revealed a significant
difference (P < 0.025) in the recurrence
rate between the two groups, the rate being
greater in group 3.
Comparison of Preoperative CEA in
Groups 2 and 3
Individual preoperative and postoperative
CEA values in groups 2 and 3 are shown
in Fig. 2. In group 2 the preoperative CEA
values ranged from 3.2 to 11.6 ng/ml (mean
and SD, 5.3 ± 2.8); in group 3 the levels
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TABLE II.—C omparison of C ancer R ecurrence R ates
Group
1

Follow-up,
mo
0 — 6
6 — 12
12 — 18

Observed Expected
0
1
4

2*

V.

2

v.

Observed Expected Observed Expected

0
1.53
3.88

0
1
1

0
0.47
1.12

0
1
1

Jt
Observed Expected

1.50
3.67
0.83

3
5
0

1.50
2.33
0.17

PLASMA CEA (ng/ml)

*X2 = 0.795; P (2 degrees of freedom) > 0.70.
tx2 = 8.210; P (2 degrees of freedom) < 0.025.

GROUP 2

GROUP 3

Fig. 2.—Preoperative and postoperative plasma
CEA concentrations in groups 2 and 3. Vertical
bars indicate mean ± SE.

ranged from 4.6 to 25.0 ng/ml (mean and
SD, 12.7 ± 7.0). The difference in the preoperative CEA values between the two
groups was statistically significant (P <
0.025).
D iscussion

Since the development of a radioimmuno
assay for plasma CEA, the test has been
widely used for the diagnosis and postopera
tive follow-up of patients with colonic can
cer. The test is of limited diagnostic value
inasmuch as varying proportions of patients
with proven cancer of the colon have a nor
mal plasma CEA concentration (< 2.5
ng/m l),3' 6 but the test has proved valuable
in reflecting the extent of disease.3' 8 These

findings led us to examine the prognostic
use of initial (pre- and postoperative) CEA
values in the subsequent follow-up of pa
tients without reference to pathologic stages
of disease. We emphasized the immediate
postoperative CEA values in relation to
cancer recurrence.
The data show that patients with abnor
mal preoperative CEA concentrations but
normal postoperative concentrations (group
2) had a rate of cancer recurrence similar
to group 1 patients with normal values preand postoperatively. However, the recur
rence rate in group 2 patients was signifi
cantly lower than of group 3 patients, whose
CEA values remained abnormal postoper
atively, implying that surgery was more
effective in group 2 than in group 3. The
average preoperative CEA concentration was
significantly higher in group 3 than in group
2, probably because of the extent of the
disease in group 3.
We conclude that preoperative and im
mediate postoperative CEA concentrations
are valuable in predicting the recurrence of
colonic cancer after clinically curative sur
gery. Systemic antitumour therapy may be
considered on the basis of the postoperative
CEA value.
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CANADIAN SURGERY DURING THE FRENCH REGIME, 1608 TO 1763*
R. A. MACBETH, MD, FRCS[C]t

can conveniently be divided into four broad
periods, each approximately a century in
duration. The first period may be referred
to as the Age of Discovery. It extended from
1497, when Giovanni Caboto (John Cabot),
under letters patent from Henry VII of
England, first explored the Atlantic sea
board of Canada, through the period repre
sented by the three remarkable voyages of
discovery of Jacques Cartier to the Gulf of
St. Lawrence and St. Lawrence River under
the patronage of Francois I of France, to
1608, when the age of colonization began.
Medically, this period involves the study of
the tantalizing but fragmentary evidence
that supports the contention that medical
personnel were included in the ship’s com
pany during those early voyages and the
conditions with which they were obliged to
contend.
L'histoire de la medecine au Canada depuis
I'etablissement de Quebec par Champlain en
The second period is precise in its limits
1608 jusqu'au Traite de Paris en 1763, par lequel
and incontestable in its documentation. It
le Canada a ete cede des Francais aux Anglais,
is commonly referred to as the Age of Settle
represente une des epoques les plus frappantes
ment or as the Period of the French .Regime.
dans l’histoire de la chirurgie canadienne. Les
It began on July 3, 1608, when Samuel de
medecins brillaient par leur absence et la me
Champlain established his Habitation at
decine qui a ete disponible a la Nouvelle France
Quebec, and extended through a century
etait fournie par des chirurgiens, ou des apothiand a half of hardship and conflict to 1763
caires, ou des individus qui se passaient pour
when, at the First Treaty of Paris, Canada
tel. Des croquis des vies de cinq chirurgiens
(Bonnerme, Giffard, Goupil, Bouchard et Sarra
was ceded, for the last time, to Britain.
zin), un apothicaire (Hebert) et un medecin
The third period is delimited more by
(Gaultier) sont presentes pour mettre en vedette
what precedes and what follows it than by
des facettes diverses des soins medicaux et le
its own distinctive features. The term, the
role important qui a ete joue par des praticiens
Age of Transition, or perhaps the Period
medicaux dans le developpement du Canada
of the Early British Regime, appears a rea
pendant cette epoque. En plus, cette etude fait
sonable designation for the century extend
connaitre la lutte entre I'approche philosophique
ing from 1763 to 1867. Medically, this
des medecins et contre la mentalite pragmatique des chirurgiens en France au XVIIeme sieperiod was highlighted by the initiation of
cle.
“modern” medical education in this country
when, in 1829, the Montreal Medical Insti
The history of Canada, and with it the his tute of 1824 (an outgrowth of the Montreal
tory of medicine and surgery in this country, General Hospital, which was built in 1822)
was engrafted on McGill University (which
*Presented in part at the XXV International Con
gress for the History of Medicine, Quebec, PQ, had been founded in 1819) and Canada’s
first medical school was born.
Aug. 21-28, 1976.
The fourth, or modern period, is ap
tFrom the departments of surgery, Dalhousie
University, Halifax, NS and the Saint John propriately designated as the Age of Con
General Hospital, Saint John, NB.
federation and extends from 1867, when
Reprint requests to: Dr. R. A. Macbeth, 310 confederation of the Canadian provinces
Saint John General Hospital, Saint John, NB
was achieved, up until the present.
E2L 4L2.

The history of medicine in Canada, from the
establishment of Quebec by Champlain in 1608
to the ceding of Canada to the British by the
French at the Treaty of Paris in 1763, represents
one of the most colourful periods in the history
of Canadian surgery. Physicians were notable by
their absence and what medicine was available
in La Nouvelle France was provided almost ex
clusively by surgeons, or apothecaries, or in
dividuals who posed as such. Sketches from the
lives of five surgeons (Bonnerme, Giffard, Goupil, Bouchard and Sarrazin), an apothecary (He
bert) and a physician; (Gaultier), are presented
to highlight various facets of medical care and
the leadership role played by medical practi
tioners in the development of Canada during
that period. In addition the study reveals the
conflict between the philosophical approach of
the physician and the pragmatic approach of
the surgeon in 17th century France.
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Although this presentation contributes no
new or original material concerning Cana
dian surgery during the French regime, the
history of the French regime is unknown to
most anglophone Canadians. Much of the
background material is published only in
French, and often in ancient French, and a
large share of the source material, both
French and English, is held in special library
collections and is not available on a loan
basis.
B ackground

At the outset it is important to establish
certain facts regarding the organization of
the medical profession in France and cer
tain features that characterized the physi
cian, the surgeon and the apothecary of
that era. This is not to suggest, as Nadeau1
is careful to point out, that the organization
of the medical services in New France simu
lated those in the mother country. Every
thing about life in the embryo colony de
manded a new approach to the provision of
medical care, as it did to virtually every
other type of service. However, the men who
fashioned the medical structure of New
France were part of a medical hierarchy
that had taken centuries to develop and
from whose basic tenets they were unable
totally to divorce themselves.
The Surgeon
Gelfand2 has stated that the dichotomy
between physician and surgeon had its
origins in the Middle Ages and that by the
dawning of the 17th century in France it
had reached a point where the physician, a
member of the Faculty of Medicine at Paris
or one of the provincial university cities,
was identified as a scholar and theoretician
while the prototype of the lowly surgeon
was an uneducated, apprentice-trained
craftsman. Earlier, rare exceptions existed
to this model of the surgeon in that a rela
tively ksmall group of “educated” surgeons
maintained a precarious existence as mem
bers of the College of St. Come.*
*Come or Cosme is the French equivalent of
Cosmas, who, with his brother Damian, suffered
martyrdom as a Christian under the Roman em 
peror Diocletian in about 295 A D. The brothers
are usually considered to be the first Christian
physicians. Both were canonized and Saint Cosmas
is commonly considered the patron saint of sur
geons.
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In 1656 the College of St. Come merged
with the guild of barbers and in 1660 the
Parliament of Paris declared that hence
forth all surgeons were officially barbersurgeons and, as such, subordinate to the
Faculty of Medicine. It took 83 years, an
operation for anal fistula on Louis XIV,
and the combined persuasion of a distin
guished succession of “first surgeons to the
king” (including Charles Frangois Felix,
Georges Mareschal and Frangois de la Pey
ronie) before surgery emerged as a re
spectable and independent profession. The
milestones along the route included the
establishment of five endowed teaching
chairs in surgery by Louis XV at St. Come
in 1724, the achievement of the right of
censorship of surgical publications by sur
geons in 1730 and the formation of the
prestigious Academie Royale de Chirurgie
in 1731. All these functions had previously
been vested in the powerful Faculty of
Medicine, to which all surgeons were sub
servient. The final triumph for the surgeons
came in 1743 when Louis XV terminated
the union of surgeons and barbers, defined
the exclusive boundaries of the areas of
activity for each group, and finally made
surgery an art savant and a “true science”
by requiring that prospective surgeons be
taught Latin and philosophy and acquire a
master of arts degree from the university
prior to becoming a master surgeon.2
Although the emancipation of surgery in
France corresponds with the final phases
of the French regime in Canada, throughout
the period under discussion the surgeon
was classed as a labourer, not a professional.
Nadeau1 has described the surgeons’ status
well, although his words may suffer in
translation.
He was a man of the working class, he did not
practise a profession but rather a trade. He was
therefore identified as a member of the working
class at the same social level as, for example,
the armourers, carpenters, and shoemakers . . !
The Physician was able to become a baron, count,
or marquis since his profession was the product
of the activity of the mind and not of the work
of the hands, but it was forbidden that the surgeon
aspire to nobility. His working class status ex
cluded him even from the bourgeoisie. Surgeons
were the servants of the physicians who scorned
them and demanded respect and obedience from
them, as well as a subordination that the physician
almost came to believe was derived from God.
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Surgeons in Canada under the French
regime were referred to by the use of various
qualifying words or phrases, a practice that
has added immeasurably to the problems of
the historian. Frequently, too, the same in
dividual has been identified differently by
different authors, or even the same author
at different times. (Roland,3 briefly, and
Nadeau,1 extensively, have discussed this
point and should be consulted for further
clarification with respect to it.) Although it
is clearly an oversimplification, individuals
who treat disease actively by manipulation
or operation will all be referred to in this
paper simply as surgeons. It is appreciated
that most, if qualified at all, were doubtless
barber—surgeons. A few may have been
master surgeons. However, it is difficult to
be precise on this point.
The Physician
What, then, of the French physician of
this period? Did he justify this exalted posi
tion and was his opinion of himself shared
by his contemporary nonmedical colleagues?
Again, Nadeau’s1 impressive description is
well worth translation.
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period of which, fortunately, an English
translation is available.5 It is said to be
anonymous and goes as follows:
First of the pedant you borrow the air,
And with a long wig cover up all of your hair:
Then trick out your habit with fur and with satin,
And constantly babble in Greek and in Latin.
In this combination, you’ll readily see,
You’ve most all that’s neded to be an M.D.

When one appreciates the grandeur of
the physician of the Paris Faculty of Medi
cine in full dress one can well understand
his disinclination to soil his hands, for he
was indeed an imposing spectacle. Delau
nay4 has written that he wore a purple
cassock and over that a scarlet cloak with
an ermine hood. At his neck he wore the
usual bands and on his head the square cap
(le bonnet carre) with a crimson tassel. He
also describes the physician’s costume at
Reims, Montpellier and Poitiers and one
forms the impression that they must surely
be in competition to achieve the most strik
ing combination of form and colour. Fig. 1
illustrates a Dutch, rather than a French
physician, of the 17th century examining the
pulse of his patient, as portrayed by Jan

The doctor of medicine disdained menial tasks
and, in assuming his noble role, shut himself off
from the world around him. He taught anatomy
but was careful not to touch the cadaver. While
he spoke, seated in his elevated chair, a prosector,
most often a surgeon, handled the scalpel. The
physician considered that he demeaned himself
by carrying out a surgical procedure. If he had
been a surgeon before receiving “le bonnet”* he
had to promise to never again soil his hands by
engaging in that trade. Moreover, in Paris, he
was required to renounce his membership in the
surgeon’s guild by means of an oath taken before
a notary in order to preserve the dignity of the
medical corporation pure and intact . . . While
the surgeons improved their position through
perfecting themselves in their art, the physicians
refused to budge. Full of their own dignity,
speaking Latin, proclaiming the preeminence of
their profession, they extended their haughty
despotism over all that which concerned the art
of healing and obstinately maintained a fanatical
respect for tradition and looked upon all progress
with horror.

Physicians were the object of ridicule in
the theatre and the literature of their day.
Delaunay4 quoted a popular jingle of that
*The academic cap (le bonnet) is used figurative
ly as the badge that identifies the physician as
holding a doctorate of medicine.

Fig. 1.—Physician examining pulse of patient.
Painting by Jan Steen (1626-79) in the Rijksmuseum, Amsterdam. (Reproduced from H uard P,
G rm ek MD: La Chirurgie Moderne. Ses Debuts en
Occident: XV 1\ X V l l ‘\ X V IIt Siecles, Paris, Dacosta, 1968.)
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Steen. It is more striking in colour but
makes its point even in black and white.

The Apothecary
The physician of 17th-century France
presents such a ridiculous picture that one
has difficulty resisting the temptation to
spend more time describing his foibles than
is justified by his medical importance, at
least in the New World. The apothecary, on
the other hand, was medically a far more
useful citizen. Like the surgeon, he was
classed as a tradesman and was equally the
object of the scorn of the physician. Some
insight into his training is given by Drolet6
in his brief biography of Florent Bonnemere,
a Jesuit lay brother and apothecary who
served in Canada under the French regime.
He states:

V o l 20

there had been no physicians in Canada and
quoted the scoffers as noting that no one
was apparently the worse off as a result.
S e v e n P r a c t it io n e r s o f t h e
F r e n c h R e g im e

This, then, is the background of our over
view of the activities, medical and other
wise, of surgeons and apothecaries in this
country commencing with that memorable
day, July 3, 1608, when Champlain estab
lished, at Quebec, the first Canadian colony
that was to survive. No authentic portrait of
Champlain exists but he was a prolific re
corder of the events that he witnessed and
the geographic features and the flora of the
regions he visited. He has left us the draw
ing of his Habitation at Quebec, reproduced
in Fig. 2.

In the 17th century [the apothecary’s art in France
was] controlled by a guild just as surgery was.
The apothecaries had their own college, and after
an apprenticeship of seven years they had to sub
mit a master’s thesis and a pharmaceutical “mas
terpiece”. Their principal function was that of
preparing medicines as prescribed by doctors;
they were obliged to deliver them to the patient’s
home and to observe their effect.

However, it is clear that in New France
the apothecaries functioned as independent
practitioners, in no way dependent on the
prescription of the physician. There were,
in fact, virtually no physicians available to
write prescriptions.
Again we can do no better than refer to
Nadeau1 in attempting to determine the
relative importance of these widely divergent
practitioners of the healing art. He advises
us that:
during the entire French Regime, only two physi
cians practised their art throughout the breadth
of the colony — three if one counts Bonamour
who made haste to return to France shortly after
his arrival. In addition, of these two physicians
Sarrazin, the best known, had been a surgeon
and remained one until the end of his life in spite
of the prejudice associated with this craft. The
history of medicine in this country is then, above
all, a history of surgery and of surgeons.

Although not included in this quotation
Nadeau’s view would be consistent with the
inclusion of the apothecary as worthy of
a place in the history of medicine of this
epoch in New France. Boissonnault7 ex
pressed the same sentiments succinctly: he
observed that during almost 150 years

Fig. 2.—Champlain’s Habitation at Quebec.
(Reproduced from C hamplain S d e : Oeuvres de
Champlain, vol 2 (1608-1613). Reprinted, trans
lated and annotated by Biggar HP (editor),
Toronto, Champlain Society Publications, new
series, 1925.)

The task of synthesis is not easy, for the
period under review is lengthy and includes
between 150 and 200 surgeons and apo
thecaries. The seven individuals chosen for
inclusion have been selected to emphasize
a particular point and are not necessarily
representative of the entire group. As it
turns out, all seven appear to have been
accepted as highly competent and reputable
practitioners of their art. This alone would
perhaps make them unique. Leblond8 re
minds us that:
the laws at the time forbade a ship to leave
France on a voyage to the colonies without a
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surgeon or an assistant surgeon on its staff. This
man often remained in the colony and estab
lished a practice, something he could not have
done in France. These newcomers were far from
being fully qualified. Many had no training what
soever.

our sample is in no sense representative of
the total colonial medical service of that
day, but it does highlight the reawakening
of scientific thought, even in a remote co
lonial setting.

Maude Abbott9 would encourage us to
approach the 17th century as two distinct
and unique half-centuries. She refers us to
Ornstein’s thesis that the first half-century
was characterized by individual experiment
and discovery and the formulation of the
elemental laws governing science, while the
second half was characterized as a period
of correlation when scientists joined to
gether in groups to form the great scientific
societies of the day for the discussion, con
solidation and diffusion of this new knowl
edge. Abbott then identified a parallel in
the pattern of activity of medical personnel
in Canada of the same era. The foundations
of this country were laid in the first half
of the 17th century by a few dedicated in
dividuals and individualists, among them
surgeons and apothecaries. While these
same persons served the modest colony
medically, often with great devotion and
distinction, their main claim to a place in
the annals of history was their nonmedical
activities. In putting this period in perspec
tive it should be remembered that it was
indeed a modest band that clung tenacious
ly to life in this harsh land. Twenty-five
souls passed that first winter in Quebec
with Champlain of whom 15 died before
spring. Forty years later in 1648, at mid
century, the entire population of New
France was only 241 persons.9
New France in the second half of the
17th century and early 18th century was
completely different; in 1663 New France
became a royal colony and as a result of
the stimulus this gave to immigration, its
population exceeded 15 000 by 1698.9 This
made possible a medical organization capa
ble of sustaining the type of surgeonscientist who represented the colonial arm
of those great scientific societies that charac
terized the mother country of that era. Two
among this small but illustrious band will
be chosen to exemplify this aspect of colonial
medical life. Since there were an additional
94 documented medical practitioners in the
colony in the latter half of the 17th century,

Bonnerme
Among the hardy band that landed at
Quebec with Champlain in 1608 was a
surgeon, identified only as Bonnerme. He
might have gone completely unidentified
were it not for his implication, in error, in
a plot on Champlain’s life shortly after their
arrival. Biggar10 has translated Champlain’s
own account of the incident in these words:
“The same day I had six pairs of handcuffs
made for the authors of the plot, one for
our surgeon, named Bonnerme, one for an
other man named La Taille, whom the four
conspirators had accused, which charge how
ever turned out to be false and this was the
justification for giving them their liberty.”
Justice in those days was carried out with
speed and vigour. Jean Duval, the instigator
of the plot, was hung and his head displayed
on a pike from the highest roof of the
Habitation, and his three accomplices spent
the remainder of their lives in the gal
leys.11- 12 Although Bonnerme was totally
exonerated his life was not long spared, as
Champlain10 records:
The scurvy began very late, that is in February,
and lasted until the middle of April. Eighteen
were struck down with it and of these ten died;
and five others died of dysentery. I had some
of them opened to see if they were affected like
those I had seen in the other settlements. The
same conditions were found. Some time after
our surgeon died. All this gave us much trouble,
on account of the difficulty we had in nursing
the sick.

The first harsh winter in the New World
had claimed its first surgeon. He would not
be the last.
Louis Hebert
More fortunate was the apothecary Louis
Hebert.9- 13’ 14 He arrived at Quebec with
his family in 1617 at age 40 and in the 10
years of life remaining to him established
the agricultural base for the colony which
was to assure its survival. As the first set
tler he is remembered as Le Pere de la
Nouvelle-Franee, and the artist C. W.
Jefferys presents him in his traditional role

76

THE CANADIAN JOURNAL OF SURGERY

Vol. 20

and son-in-law that they “had the respect
and affection of the entire community, and
their homes were long a centre of hospitali
ty and of refuge from the common dan
gers”.9 One would have thought that his
life would have been a tranquil one, com
plicated only by the physical hardships of
the country itself. However, this was not
the case. The very attribute that made him
pre-eminent among those early settlers, his
love of the land and his ability to wrest a
bountiful harvest from it by dint of knowl
edge and hard labour, brought him into
conflict with the powerful trading companies
who could see no further than the imme
diate and rich returns available from ex
ploiting the fur trade. They looked upon
colonization as a threat and did everything
in their power to oppose and obstruct his
attempts at farming and the disposal of his
produce. However, right triumphed and He
bert’s industry, courage and integrity event
ually won the day and secured the colony.

Fig. 3.—Louis Hebert (courtesy of the Public
Archives of Canada).

as an apothecary (Fig. 3). Hebert was not
a stranger to the New World. He spent the
winter of 1604-5 on lie St. Croix and that
of 1606-7 at Port Royal in Acadia with
Champlain and returned to the latter site,
accompanied by his wife, with the little
band that Poutrincourt hoped to establish
there in 1610. They might well have suc
ceeded had Port Royal not been destroyed
by the English under Argali, in 1613, and
the colonists forced to return to France.
There is ample evidence from contem
porary records,9’ 13 referring both to He
bert’s sojourn in Acadia and his later life
in Quebec, to confirm that he practised his
apothecary’s craft with skill. Moreover, he
must have been a kindly man for he “en
joyed the confidence also of the Indians,
whom he, in contrast to many of his con
temporaries, considered as intelligent hu
man beings lacking only in education. Many
instances bear witness to their respect and
affection for him.”13 He was equally re
spected by the other colonists and it is re
corded of the Heberts and their daughter

Robert Giffard
If Hebert was the pioneer colonistapothecary, the surgeon Robert Giffard9- 15
achieved the distinction of becoming the
first colonizing seigneur. He first came to
Quebec in 1627, the year of Hebert’s death,
as surgeon to a vessel involved in the fur
trade. He liked what he saw that summer
in the wooded country around Beauport,
built himself a log cabin for future use, and
determined to return. His attempt to return
the following year proved disastrous. War
had broken out between France and Eng
land and the ship on which he sailed was
intercepted by an English flotilla in the St.
Lawrence with the loss of all of the equip
ment he had brought with him to start a
colony. In recognition of his loss and as a
means of assisting themselves in meeting
their commitments with respect to immigra
tion, the Compagnie de la Nouvelle France
granted Giffard the first seigneury in Can
ada, that at Beauport, in 1634. “This was
the first time that a title of nobility was
conferred upon a Canadian settler, and
nobly did Giffard fulfil his obligations, for
he immediately took the important step of
arranging to bring out, with his wife and
five children, a number of artisans and
labourers from Perche in Normandy.” 9 At
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the census of 1666 the Seigneury of Beauport consisted of at least 29 households and
184 persons.15 Giffard certainly more than
fulfilled his obligation as a colonizer.
Nor should Robert Giffard be discounted
as a surgeon. He was the first to bear the
title, King’s Physician, in the New World.
The fact that in the colony a surgeon, or
even an apothecary if need be, could hold
the title of (King’s) Physician was an ano
maly that could not have occurred in France,
and it is a practice that has apparently led
to confusion by historians. Nadeau1 goes
to great pains to clarify this situation. By
royal brevet a surgeon could be given the
title and the administrative rights and
privileges of King’s Physician in Canada.
In essence this made him the senior medical
official in the colony. However, royal author
ity could not create a physician in the sense
of an individual holding the doctorate of
medicine (le bonnet). The term is therefore
an unfortunate one and much confusion
could have been avoided had some other
title been used to identify this prestigious
administrative position.
One of the functions of the King’s Physi
cian was that he was physician to the king’s
hospital: that is, l’Hotel-Dieu de Quebec.
Giffard was appointed to both offices in
1640. L’Hotel-Dieu de Quebec was Can
ada’s first hospital and is the fifth oldest
hospital in the British Commonwealth.10
The amazing story of its origin in 1639 un
der the patronage of the Duchesse d’Aiguillon, niece of Cardinal Richelieu, is briefly
outlined by Abbott9 and in the biography
of its first superior, Sister Saint-Ignace, in
the “Dictionary of Canadian Biography”.17
It is completely recorded in French in Casgrain’s book18 but the emphasis here is a
religious rather than a medical one.
While many references indicate Giffard’s
humanity and value to the colony as a sur
geon, he will be remembered primarily as
Canada’s first colonizing seigneur. His
manor house was completed in 1636 and
forms the focus of the drawing of Orson
Lowell depicting Jean Guiou (Guyon) du
Buisson, one of Giffard’s principal tenants,
carrying out the formal act of homage be
fore Giffard’s representative following settle
ment of some litigation (Fig. 4). It provides
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an interesting insight into the practices of
French feudal law.
Rene Goupil
A prime role was thus played by two of
the early apothecaries and surgeons in rela
tion to the colonization of New France in
an era when havoc was wrought upon the
settlers by those cruel and bitterly cold
winters. However, the climate was not their
only antagonist in their struggle for survival.
The Indian, or peau-rouge as he was called,
proved to be a formidable foe. The tragic
story of Rene Goupil is only one of many
that could be used to illustrate this point.
Goupil9’ 19 was already a Paris surgeon
when he entered the Jesuit order as a novi
ciate in 1639. Subsequently, because of
deafness, he was forced to discontinue his
noviciate but he continued his association
with the order as a donne. In 1640 he was

Fig. 4.—Formal act of homage before seigneurial manor of Robert Giffard at Quebec. (Repro
duced by permission from A bbott ME: History
of Medicine in Province of Quebec, Toronto,
Macmillan, 1931.)
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living in Quebec. At the Jesuit mission there
his surgical skills were much appreciated.
In the summer of 1642 he set out for Hu
ron country in the company of one of the
Jesuit fathers, Isaac Jogues, another donne,
and a band of friendly Indians, intent on
making his surgical skills available in that
isolated area. On Aug. 22 they were at
tacked by the Iroquois and Goupil was taken
prisoner. After 6 weeks of the most horri
fying torture he was killed by a blow on the
head from a tomahawk. His martyrdom was
witnessed and reported by Father Jogues.
He is venerated as the first Jesuit martyr in
Canada and was canonized by Pope Pius
XI in 1930. The practice of medicine was
indeed hazardous in New France in the 17th
century.
Etienne Bouchard
Etienne Bouchard, a surgeon from Paris,
demands inclusion in our narrative for yet
another reason. In 1655 he introduced the
first prepaid medical program in Can
ada.9’ 16’ 20 Bouchard came to Montreal
in 1653 under agreement to La Societe
Notre-Dame de Montreal. Two other sur
geons arrived in Montreal at the same time,
which may have contributed to Bouchard’s
decision to initiate negotiations that led to
the termination of his contract. He then
completed an agreement with 26 heads of
families in that city “to treat and supply
with medicines themselves, their wives and
families, both born and to be born” in re
turn for 100 sous for each person so
treated.9 Nadeau20 provides us with a some
what different version of the method of
payment. He suggests that Bouchard re
ceived “ 100 sous paid annually in two in
stalments by each settler”. Unfortunately
Ahern11 is completely silent in respect to
this aspect of Bouchard’s practice. In any
case the contract, complete with exclusions,
is amazingly similar in general terms to
many available today. The only real differ
ence is the modest price.
*

*

*

One might, with some justification, be
critical of the foregoing as medical history
and consider it rather as contributions to
general history by practitioners of medicine
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in the broadest sense. However, this com
plaint could hardly be levelled at two dis
tinguished medical scientists who exemplify
the corporate reawakening of scientific
thought in the latter part of the 17th and
early 18th centuries — Michel Sarrazin and
Jean-Frangois Gaultier.
Michel Sarrazin
The life of Michel Sarrazin has been
briefly summarized in a previous issue of
this journal by Caron,14 while Abbott,9
Ahern,11 and Rousseau21 have provided
us with fairly extensive accounts of his con
tributions to medicine and science. In addi
tion a small book written by Vallee,22 de
voted entirely to this Canadian pioneer, is
available. However, he emerges as the first
real scientist in New France and, as such,
it is appropriate to review briefly his career
and accomplishments.
Sarrazin was born in 1659 at Nuits-sousBaune in Burgundy and first came to New
France in 1685 as a surgeon to the marine
corps. During his initial stay of 9 years he
achieved an enviable reputation for surgical
skill, but there was no suggestion, during
this period, of the major contribution that
he was to make in a variety of spheres in
later life. Apparently towards the end of
this period he became ill and went through
a period of depression, during which he at
tempted to enter the priesthood. Fortunately
for the history of medicine in this country
the superior general of the Sulpicians re
ported, “The more we have examined both
his present and past state of mind, the more
we have been convinced that there was no
indication of a divine vocation to justify this
change.”21 He was therefore advised to
resume his former occupation. At this point,
in 1694, he returned to France and enrolled
in the medical faculty at Reims. During his
studies he manifested a particular interest
in botany and this was to provide him with
an avocation at which he achieved distinc
tion equal to that which he achieved as a
surgeon. He received his bonnet in 1697
and returned to Canada the same year.
Sarrazin’s preparatory studies were car
ried out at l’Ecole de Medecine de Paris
and the associated Hopital de l’Hotel-Dieu.
Abbott9 gives us some insight into the im
pact of such an experience.
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To understand the tremendous intellectual im
petus which a University training in Paris at that
time must have brought to this mature student,
whose mind had been sharpened by hard-won
experience, one must recall the immense changes
that were taking place in medical thought at that
time. The cognate sciences of physiology and
pathology had been founded through the labours
of Harvey and others, while the English clinician
Sydenham, who died in 1689, had, by his power
of observation and method of delineation of
disease entities, brought these new found prin
ciples to a focus in the great science of clinical
medicine. LTcole de Medecine itself was full of
eager disputation of the new ideas that were
trembling in the air; and two great scientific
institutions allied to medicine and ministering to
its advancement, both of which became to Sarrazin an avenue and source of inspiration for his
future activities, were being actively fostered un
der the paternal government of Louis XIV. These
were: the Jardin Royal des Plantes . . . and the
Academie Royale des Sciences, founded by C ol
bert in 1666 and reorganized in 1699.

As a result of his activities in the field of
botany and zoology Sarrazin was named a
corresponding member of the academie in
1699, the same year that Sir Isaac Newton
was similarly honoured.
In addition to making an enormous con
tribution as a naturalist, Sarrazin continued
to give devoted service to the practice of
medicine. Also, although now a physician,
he continued to combine this with the prac
tice of surgery in spite of the prejudice
against such activity, at least in France it
self. On his return to the colony in 1697,
he was immediately appointed to the staff
of l’Hotel-Dieu, and his devoted service dur
ing the recurrent devastation that accom
panied a series of serious epidemics —
typhus, influenza, smallpox and yellow
fever — has been recorded. He also appears
to have achieved a degree of success in their
treatment that was unusual for that period.
In 1700 he was officially appointed King’s
Physician and became the senior medical
representative in the entire colony.
Sarrazin enjoyed equal success, and
achieved much distinction, as a surgeon.
In 1700, long before the birth of either
Pasteur or Lister, or the introduction of
anesthesia, he successfully performed a
breast amputation on Sister Marie Barbier
de l’Assomption.23 Although we are told
that the lesion was a cancer she lived, in
excellent health, for 19 years after her
surgery. The records of l’Hotel-Dieu de

Fig. 5.—Pitcher plant (Sarracena purpurea),
floral emblem of Newfoundland (courtesy of the
Department of tourism, Government of N ew 
foundland and Labrador).

Quebec report that he performed this oper
ation on at least two other occasions as well
as numerous other procedures that, at the
time, would be considered major surgical
undertakings.
As a botanist Sarrazin submitted innumer
able specimens (over 200 in 1704 alone)
of the flora of Canada to the Jardin Royal
des Plantes through Tournefort, and later
Reaumur, through whom he “corresponded”
with the academie. These were accompanied
by meticulous notes as to their care and the
natural conditions of their growth. His de
tailed description of the “pitcher plant”
(Fig. 5), the floral emblem of Newfound
land, led Tournefort to name it Sarracena
purpurea after him. He also was responsible
for the industrialization, if not the discovery,
of maple syrup, the recognition and popu
larization of the blueberry as an edible fruit,
and, in addition, has his name associated
with Indian corn or maize, which is com
monly referred to as Sarracen corn.
As a zoologist he dissected, and prepared
detailed descriptions of the anatomy of,
many of Canada’s native animals, including
the muskrat, the beaver, the porcupine and
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even the bear and the caribou. One record
is, however, incomplete — that of his dis
section of a skunk. Of his experience he
wrote, “It had a dreadful smell, capable
qf making a whole canton desert.” 0 The
accuracy of his minute description of the
features of the organs of these animals is
all the more amazing when one realizes that
his instruments included only a surgical dis
secting set and a hand lens. Many of his
submissions were published in the reports of
the academie and have been preserved.
Sarrazin died in 1734 at the age of 75.
His major administrative achievement, apart
from his appointment as King’s Physician,
was his appointment to the Conseil Superieur de Quebec in 1707. However, it is as
an outstanding physician and surgeon and
as a distinguished botanist and zoologist that
he deserves our study. One should remem
ber, too, that major difficulties attended the
pursuit of these objectives in Canada be
tween 1685 and 1734. These difficulties can
hardly be expressed more effectively than in
Sarrazin’s own words:* “I do not know
whether it is believed that one botanizes
in Canada under the same conditions as in
France. I could more easily traverse the
whole of Europe, and with less danger, than
I could cover 100 leagues in Canada, a
much riskier undertaking.” 21
Although Caron14 has provided us with
a picture of Sarrazin, Rousseau21 is of the
opinion that no authentic likeness is known
to exist and believes the often displayed
photograph to be rather that of a French
doctor of about the same period.
Jean-Frangois Gaultier
Although of different temperament and
personality we find a worthy successor to
Sarrazin in Jean-Fran§ois Gaultier.0- 24
There is also a remarkable parallelism in
their careers. Gaultier was, however, a physi
cian and a doctor of medicine and had never
been a surgeon. Like Sarrazin, he was
named King’s Physician in Canada (1741),
and was appointed to the Conseil Superieur
of the colony in 1744. In addition he was
♦Included in a letter to Reaumur in 1726 and
published as an appendix in Vallee’s book;22 also
included, in translation, by Rousseau.21
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named a corresponding member of the Aca
demie Royale des Sciences of Paris in 1745,
reporting through Duhamel du Monceau.
Gaultier arrived at Quebec in 1742. He
immediately profited as a result of the
pioneering botanical efforts of Sarrazin and
the interest of the temporary governor
Galissoniere and. was able to achieve an
effective organization for the collection of
specimens throughout the colony. Kalm,
whom Gaultier assisted with his botanical
studies in Canada, recognized the latter’s
indispensable assistance by dedicating the
genus Gaultheria to him. Although the genus
includes some 150 species of wide geo
graphic distribution, the best known medi
cally is certainly Gaultheria procumbens,
from which oil of wintergreen is obtained.
Gaultier continued to send shipments of
plants, accompanied by voluminous notes,
to the French academie. However, even to
day, the significance of his personal con
tribution to botany remains to be assessed
since only a small portion of his manuscripts
have been published and the remainder,
many of them only recently rediscovered,
have never been critically assessed.
Rather than zoology it was meteorology
that was Gaultier’s second, or perhaps it
should be considered his prime, nonmedical
scientific avocation. In 1742 he set up Can
ada’s first meteorologic station. His log
runs from that date to 1756 and was, in
part, published by Duhamel du Monceau
in the memoires of the academie. Unfor
tunately Gaultier’s observations in this re
gard, like his botanical reports, have never
been critically analyzed and their true sig
nificance is therefore a matter of conjecture.
In his meteorologic reports he did, however,
include much valuable comment about life
in the colony.
Since the archives of l’Hotel-Dieu de
Quebec were destroyed in a fire in 1755
we know little directly of Gaultier’s medical
practice. However, his meteorologic reports
contained a monthly bulletin on the state
of the health of the colony including the
frequency of various diseases and the reme
dies prescribed in their treatment. A partial
list of some of the medicines used was given
by Boivin.24 He encouraged the use of
wintergreen tea and tested the antiscorbutic

J a n u a r y 1977

THE C A N A D IA N JO U R N A L OF SURGERY

properties of the spruce tree, recommending
spruce beer in treatment of scurvy.
Gaultier has been characterized as an
encyclopedist and as a scientist who effec
tively performed the responsibilities assigned
to him but who lacked the aggressive selfmotivating scientific spirit of Sarrazin. It is,
however, perhaps too early to pronounce
this verdict since the evidence is far from
completely evaluated. In any case he was
apparently respected and beloved by his
patients and compatriots. Like so many of
his fellow practitioners who succumbed to
one or other of the epidemics of those days
he died at a young age (48 years) of typhus,
which was brought to the colony in 1756
by the ship Leopard, a part of the squadron
that brought Montcalm to Canada.
*

*

*

Seven medical practitioners, five of them
surgeons, have been selected to highlight
various facets of Canadian medical practice
during the French regime. Each had an
avocation apart from medicine and it is this
that has dictated their inclusion. However,
all, according to the standards of their day,
appear to have enjoyed and amply justified
the respect and confidence of the other
colonists in their role, be it as surgeon,
apothecary or physician. One should there
fore perhaps close by re-emphasizing that
not all those who bore such designation in
New France were of the calibre of this
group and, in fact, many were downright
charlatans and quacks. At a somewhat later
date (1784) James Fisher speaking of Que
bec wrote:
I cannot help thinking, but that medicine, as it
is now practised in Canada, is materially injurious
to Population and, I do aver, that although many
Individuals are indebted to it for their lives and
the health they enjoy yet if we take the Province
at large, it would contribute to the increase of
His Majesty’s subjects were there not one of the
Oesculapian tribe in this part of British Amer
ica.25

Fisher may well have overstated his indict
ment intentionally to achieve greater em
phasis, but there is little doubt that the
individuals who practised medicine in Can
ada during the French regime represented
the complete spectrum of medical ability
and ethical standards from the very best to
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the very worst. About all they had in
common were the harsh realities of the bit
ter winter climate and the ever-present dan
ger of sudden death from some plague or
at the hand of their indomitable foe, the
Iroquois. Whatever their strengths and
weaknesses they are part of our heritage
and we would do well to come to know
them.
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DAVIS & GECK SURGICAL ESSAY AWARD
FOR RESIDENTS

^
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Davis & Geek annually awards $1000.00 to the surgical resident submitting the
best paper on a surgical topic to the Canadian Journal of Surgery. This award is in
tended to promote scientific and literary excellence among Canadian surgeons in
training.
The conditions of entry for the 1977 award are the following: —
1. Candidates shall be currently engaged in a recognized surgical residency program
leading to eligibility for the Fellowship of the Royal College of Physicians and
Surgeons of Canada in one of the surgical specialties (cardiovascular and thoracic
surgery, general surgery, neurosurgery, obstetrics and gynecology, ophthalmology,
otolaryngology, orthopedic surgery, plastic surgery and urology).
2. The material to be submitted shall be in the form of a manuscript relating to
work in which a surgical resident is or has been the prime or major investigator.
Prior oral presentation at a Royal College meeting or a Surgical Forum meeting
will not be a disqualification, but prior publication as a formal paper in a
journal will. The paper should relate to any field of surgical interest. The manu
script must conform to the style requirements of the Journal and must not
exceed 3000 words of text and six tables and/or six figures. Coauthors are
permitted on the understanding that the candidate shall be the first author and
that only the first author shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than June 30, 1977.
Each entry must be submitted to E. M. Cooperman, MD, FRCP[C], at the
office of the Canadian Journal of Surgery, PO Box 8650, Ottawa, Ont.
K1G 0G8, with a letter stating that the paper is being submitted as an entry
for the Davis & Geek Surgical Essay Award.

*

Y

*

4. All papers submitted shall be the property of the Canadian Journal of Surgery
unless returned to the author without publication.
All papers submitted will be judged by an independent committee comprising at
least one member of the editorial board of the Journal, one fellow of the Royal College
of Physicians and Surgeons of Canada, and one representative of The Canadian Medical
Association, together with other fellows invited to serve at the discretion of the three
permanent members of the committee. For the purpose of judging, the candidates will
be anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be announced
in the November 1977 issue of the Journal.
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CORRESPONDENCE
EXTRAUTERINE PREGNANCY
To the editor: The account by M. B. Quane
of a patient with an extrauterine pregnancy
that was diagnosed at 10 weeks and allowed
to continue until term {Can J Surg 19: 359,
1976) makes some interesting points about
the causes and management of this rare
occurrence. All those concerned deserve
congratulations on the successful outcome
of this particular pregnancy, and both pa
tient and obstetrician get full marks for
courage.
But it is to be hoped that Quane’s paper
does not inspire others to follow his example.
It is most unusual for an extrauterine preg
nancy to be so situated that it can continue
until the fetus is viable with reasonable
safety to the mother. A “tangerine-sized
solid mass of limited mobility in the region
of the left appendage” palpated beside a
soft, slightly bulky uterus at 10 weeks’ gesta

tion, is much more likely to indicate an
ectopic pregnancy in the interstitial portion
of the fallopian tube or in an incompletely
developed uterine cornu. In either case
rupture with massive hemorrhage will almost
certainly occur some time during the 1st or
2nd trimesters, and may be fatal.
The team I had the privilege of working
with in Jamaica managed ectopic pregnan
cies of virtually every type. We adopted the
aphorism “an ectopic unopened is an ec
topic mismanaged”. There are rare excep
tions, as in Quane’s case, but they are few
indeed.
D. B. STEWART, FRCS[C], FRCOG
Formerly professor of obstetrics
and gynecology,
University of the West Indies,
Jamaica, WI.
Present address:
Box 805,
Killarney, Man.

CRITIQUE OF ITEM 509 (SESAP II)
In the diagnosis of carcinoma of the colon, carcinoembryonic antigen (CEA) has
not proven as beneficial as original reports suggested. Response (4) is incorrect:
the procedure has not provided a useful screening test for the discovery of new
cases of colon carcinoma because the antigen is nonspecific. However, response (1)
is proper: the presence of increased levels of CEA is highly suggestive of the pres
ence of further carcinoma in patient who has had a bowel resection for carcinoma
of the colon. Measuring CEA periodically in these individuals is one valid method
of follow-up. Unfortunately, elevated levels of CEA have been found in patients
with sigmoid diverticulitis and in certain individuals with collagen diseases; there
fore response (2) and (3) are also correct.
Reference
509/1. Lebel JS, Deodhar SD, Brown, CH: Newer concepts of cancer of the colon
and rectum: Clinical evaluation of a radioimmunoassay for CEA. Dis Colon Rec
tum 15:111-115, 1972.
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REVIEWS

ANGIOGRAPHY OF POSTERIOR FOSSA
TUMORS. Samuel M. Wolpert. 196 pp.
Illust. Grune & Stratton, Inc., New York;
Longman Canada Limited, Toronto, 1976.
$27.00.

The posterior fossa is one of the more difficult
areas in neuroradiology to investigate angiographically; in spite of this the author has
succeeded in presenting the subject in a clear
concise manner.
A brief introduction to the history and
techniques of posterior fossa angiography is
followed by chapters depicting normal angio
graphic anatomy and altered anatomy pro
duced by intra- and extra-axial mass lesions.
A series of coloured plates are used to illus
trate the normal relation of arteries and veins
to the cerebellum and brain stem and also the
disturbed relations occurring in the presence
of space-occupying lesions.
A chapter on the clinical and pathologic
aspects of posterior fossa tumours adds per
spective to the descriptions of vascular dis
placements. The angiographic films are of
superior quality; the vessels are clearly marked
and easily identified. Several figures have been
mislabelled; however, I understand that an
erratum will be added to future printings. A
good list of references conveniently follows
each chapter.
Although computerized tomography has
greatly facilitated the diagnosis of these mass
lesions, posterior fossa angiography remains
an excellent diagnostic procedure. This book
is recommended to both residents and prac
tising physicians in neurosurgery and neuro
radiology.
P. W. C ooper
Department of radiology,
Sunnybrook Medical Centre,
Toronto, Ont.
ANORECTAL MALFORMATIONS AND
ASSOCIATED DISEASES. Progress in
Pediatric Surgery. Volume 9. Executive
Editors: P. P. Rickham, W. Ch. Hecker and
J. Prevot. 154 pp. Illust. University Park
Press, Baltimore, 1976. $19.50.

This is the ninth volume of the series “Pro
gress in Pediatric Surgery”. The series has
drawn from the experience of well-known
pediatric surgeons around the world, and is
authoritative and reliable throughout. This
book is not for the undergraduate; it is de

signed for the specialist in pediatric surgery,
but many articles will be of interest to the
pediatrician and general surgeon also.
Anorectal continence in the normal subject
is discussed and problems such as the nerve
supply to the large bowel and rectum, now
not clearly understood, are touched upon. The
pharmacology of neural impulse transmission
and pharmacologic anomalies in the autonomic
supply of patients with Hirschsprung’s disease
are presented and the classic operations
for the improvement of fecal incontinence in
these patients are described.
The embryology of imperforate anus (IA)
and the IA classification adopted in 1970 by
the World Congress of Paediatric Surgery in
Melbourne are discussed; descriptions of the
clinical and radiologic determinants of the
level and type of IA are excellent. The authors
have provided clear descriptions of the opera
tive modes most suitable for each of the
three levels of IA; to ensure maximal con
tinence they properly stress the necessity for
adequate assessment and a proper operative
approach.
The authors leave us with many stimulating
questions and some solutions. The text is in
tended for a select group but the style is
clear and the material well presented.
S. M ercer
Chief,
Department of surgery,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont.
COMPUTED TOMOGRAPHY OF BRAIN
AND ORBIT (EMI SCANNING). Paul F.
J. New and William R. Scott. 486 pp.
Illust. The Williams & Wilkins Company,
Baltimore; Burns & MacEachern Limited,
Toronto, 1975. $43.45.

This is the first complete text on computed
tomography of the brain. Since its publication
there have been notable technologic advances,
with many scanners besides the EMI now
available. Clinical experience has also grown
extensively since publication. However, this
book still has strong merits: the basic physical
and clinical concepts are well presented and
still apply. Figures are easily seen without
having to turn pages to read their description.
The index is well organized and complete.
Part one deals with the physical and opera
tional aspects of the EMI scanner. Both the
old 80 x 80 and the updated 160 x 160 ma-
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trices are discussed with an abundance of
clear explanatory diagrams. The chapter on
anatomic correlations is excellent. Numerous
well-labelled brain slices are presented with
the appropriate level of scan; and the appear
ance of normal structures is described in
detail, including changes with various scanning
angles.
Part two (about 75% of the text) consists
of an atlas of pathology. Most of these scans
are of the old 80 x 80 matrix. However, this is
less of a problem than would be expected
since the scans are quite free of artefacts, and
are particularly well selected to illustrate
clearly the abnormality. The range of patho
logic entities included is quite complete and
the basic appearance of lesions has not
changed appreciably in spite of the rapid ad
vances in this technique. Correlation of the
clinical history, angiogram, pneumoencephalo
gram and the nuclear scan is excellent. In the
chapter on the orbits use of the old 80 x 80
matrix detracts from the quality of the illus
trations.
In spite of the limitations, since the text
encompasses all the aspects of computed tomo
graphy scanning in a single unified source, it
is still useful reading for those interested in
learning the basic physical and clinical
aspects of this revolutionary diagnostic aid.
S. T aylor
Montreal Neurological Institute,
Montreal, PQ.
GASTROINTESTINAL
EMERGENCIES.
The Thirty-Fourth Hahnemann Symposium.
Edited by Harris R. Clearfield and Vicente
P. Dinoso, Jr. 295 pp. Illust. Grune &
Stratton, Inc., New York; Longman Canada
Limited, Toronto, 1976. $31.25.

Books dealing with emergencies are similar to
oral contraceptives in that they are most suit
ably employed before the event. None the less,
“Gastrointestinal Emergencies” is a useful
volume, even if taken as a morning-after pill.
Unlike most published symposia this is a
well-organized publication and clearly describes
the problems associated with most of the gas
trointestinal emergencies. The book includes
sections on upper gastrointestinal hemorrhage,
hepatic emergencies, mesenteric vascular dis
ease, diverticular disease, acute colitis and
pancreatitis. The final section deals with acute
diarrhea, intra-abdominal hemorrhage, com
plications of radiologic investigations and
management of complications resulting from
the ingestion of corrosive agents. Most sec
tions begin with a chapter reviewing the patho
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genesis of the emergency problem to be dis
cussed. Consideration of the diagnosis is
followed by a description of the proper man
agement. Each chapter is adequately refer
enced; the overall length of each is less than
10 pages. The organization and brevity of this
book combine to make it a handy reference
during an actual hospital emergency and a
painless bedtime refresher course.
There are criticisms, of course. The many
printing, spelling and grammatical errors are
annoying. Most topics are dealt with in an
even-handed way; however, the statement in
chapter 22 that one third of patients with toxic
megacolon may be successfully managed with
out surgery is not generally accepted and the
presentation in chapter 23 of one centre’s
unorthodox surgical approach to toxic mega
colon is inappropriate and detracts from the
overall merit of the book. It is stated in chapter
18 that 5% of patients with diverticular dissease require operation for hemorrhage. This
is an overstatement. Aggressive use of angio
graphy in the investigation of gastrointestinal
hemorrhage and mesenteric vascular disease is
advocated; this approach, if worthwhile, is
impractical at many centres.
This book is valuable as a prophylaxis
against the mishandling of gastrointestinal
emergencies; the palatability of the medicine,
however, may be impaired by the price.
W. G. T hom pso n
Associate professor of medicine,
University of Ottawa,
Ottawa Civic Hospital,
Ottawa, Ont.
H UM AN
NEUROANATOMY
(Formerly
Strong and Elwyn’s Human Neuroanatomy).
7th ed. Malcolm B. Carpenter. 741 pp.
Illust. The Williams & Wilkins Company,
Baltimore; Burns & MacEachem Limited,
Toronto, 1976. $27.50.

It is a pleasure to read a text that is so com
prehensive, lucid and current; both the author
and the publisher are to be congratulated.
Discussion of the tracts of the spinal cord and
the thalamus (diencephalon) are especially ex
tensive. Primarily directed at students, the
rather crowded text calls for creation of open
space by more subheadings, which would also
eliminate redundancies as in the descriptions of
nigral efferent fibres. It would be further re
lieved by more original diagrams, especially in
the section on the functional anatomy of the
brain stem.
There is no account of structure, innerva
tion or functional attributes of the cerebral
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vessels — a topic of major clinical importance.
Less important omissions include accounts of
the recently defined membrane properties of
neuronal soma and dendrites; the distribution
of callosal fibres; the internal organization of
autonomic ganglia; the likely roles of the
striatum in conditioning; likely roles of the
posterior commissure in split-brain patients
and callosal agenesis. Minor apparent incon
sistencies concern the blood supply of the an
terior thalamus (pages 605 and 616), the
innervation of the pineal gland (usually con
sidered to be sympathetic only) and direct
efferent fibres from the visual cortex (more
likely from areas 18 and 19). Rare misleading
constructions such as “the ependyma contri
butes to the CSF” (rather than the extracellular
fluid through the ependyma) or word confu
sions (neurotubule for microtubule) were seen.
The minor or even debatable nature of most
of these criticisms merely serves to underline
the high quality of the factual content. The
volume is of reasonable size and is well bound,
and the illustrations are good to excellent;
colour reproduction is only adequate. As in the
section on the cerebral cortex, correlation of
text and figures could be better. The small
number of grammatical errors (fewer than a
dozen and all minor) speaks well for the copy
editing.
This text is highly recommended for med
ical students. It will also be of continuing value
to residents and practising physicians in all
neurologic specialties.
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of many surgical patients; this book goes a
long way in providing appropriate guidelines to
this kind of nutritional care.
The basic science section is divided into
three parts; these are very detailed excellent
reference sources. Part 1 comprises a discus
sion on the metabolism of carbohydrates, fats
and proteins, and salt, water and vitamins. In
part 2 the sources and utilization of energy
are discussed; the chapter on the absorption
of nutrients, because of its clarity, deserves spe
cial note. Part 3 deals with the response to
starvation and stress.
In part 4 all the available techniques for
enteral and parenteral feeding are presented.
The authors then discuss the indications for
particular methods. Specific attention is drawn
to the applications of this information in pedia
trics, surgical infection, malignant disease and
organ failure syndromes. One chapter entitled
“Intestinal Fistulas and Malabsorption”,
although accurate and informative, would have
achieved its purpose better if the subjects were
divided; another devoted to a surgical approach
to the management of morbid obesity is topical
and especially interesting.
This is a well-organized, excellent reference
book for both the surgeon and the gastro
enterologist. There are many books on surgical
nutrition, but this is by far the best.
M. D eitel and M. A. A lexander
St. Joseph’s Hospital and University of Toronto,
Toronto, Ont.

A. J. L ewis
Associate professor,
University of Ottawa,
Ottawa, Ont.

VENOUS SURGERY IN THE LOWER EX
TREMITIES. Chief Editor: Kenneth G.
Swan. 442 pp. Illust. Warren H. Green,
Inc., St. Louis, 1975. $32.50.

M ANUAL OF SURGICAL NUTRITION.
American College of Surgeons Committee
on Pre and Postoperative Care. 527 pp.
Illust. W. B. Saunders Company, Philadel
phia; W. B. Saunders Company Canada
Limited, Toronto, 1975. $19.05.

This monograph is made up of a series of
manuscripts presented for a symposium on
venous surgery in the lower extremities at the
Walter Reed Army Institute of Research. Most
of the manuscripts discuss the results of ex
perimental surgery.
The importance of repairing major veins of
the extremities at the time of arterial, ortho
pedic and other reconstructive procedures is
stressed. After reviewing recent war experi
ence, the authors conclude that the amputa
tion rate decreases if venous injury is not
delayed but is repaired along with associated
arterial injury.
In a series of clinical and experimental
studies, it was clear that in venous replace
ment autogenous grafts must be used; the

Among the 36 contributors to this book are
many of the most knowledgeable persons in their
respective fields. The book opens with a brief
but complete chapter on the history of nutri
tion. This is followed by a section on the basic
science of nutrition and another on the applica
tions of this knowledge to the practice of
clinical surgery. An extensive appendix pro
vides representative samples of diets and diet
ary supplements. Special attention to proper
nutritional care is necessary for the survival
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operative technique must be error-free and
the suturing meticulous. A synthetic prosthesis
can be used for bypass in the innominate vein
and superior vena cava. Heparin is recom
mended for anticoagulant therapy. Operative
venography is reliable and follow-up veno
graphy during the first 6 weeks is recom
mended.
The authors describe a variety of noninvasive methods for measuring peripheral blood
flow; those most likely to become practical
within the next few years are described. The
description of the pathophysiology of arterio
venous fistulas is adequate.
More experimental surgery is required to
help solve the problems associated with venous
and arterial thrombosis. It is not understood
why arterial thrombosis resulting in occlusion
is usually compensated in time by collateral
circulation while after venous thrombosis, the
thrombosed vessels themselves usually recana
lize. Enzymatic dissolution of clots in clinical
practice requires more investigation and
development; some experimental work is de
scribed. Streptokinase and urokinase are the
most promising plasminogen activators.
The discussions following the papers are
excellent. Because most of the presentations
are based on experimental work, the publica
tion will be of greatest interest to the experi
mental and vascular surgeon. It is recom
mended for trainees in vascular surgery.
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interesting; here, cryosurgical techniques are
being used in the management of both com
mon and uncommon eye diseases such as
intraocular and extraocular eye tumours. The
most notable use of cryosurgery in ophthal
mology has been the treatment of herpes
keratitis in conjunction with immunotherapy.
The use of cryosurgery to achieve hemostasis
is a fundamental property of the technique.
This application is well illustrated in the
chapters on the treatment of head and neck
lesions.
The applications of cryosurgery to the treat
ment of specific lesions arising in the practice
of gynecology, urology and general surgery
are well illustrated; the applications described
for neurosurgery have been made known
because of the pioneering work of Dr. Irvine
Cooper.
This book is worth while and highly recom
mended for those interested in learning the
uses and applications of cryosurgery in all of
the surgical specialties.
H. R. Shibata
Department of surgery,
Royal Victoria Hospital,
Montreal, PQ.

R. H. Craig

Chief of surgery,
Grace Hospital,
Ottawa, Ont.
PRACTICAL CRYOSURGERY. Edited by
H. B. Holden. 168 pp. Illust. Pitman Med
ical Publishing Co. Ltd. Distributed by Year
Book Medical Publishers, Inc., Chicago,
1975. Price not stated.

This book is timely and concise. The author
describes both the advantages and the dis
advantages of cryosurgery in each specific field
where it is used.
The book opens with a short but excellent
review of the history and development of this
treatment modality; this is followed by an
authoritative chapter on the practical aspects
of cryosurgical engineering. Unfortunately a
list of the manufacturers of the equipment
described is not included.
In the rest of the book the author describes
the application of freezing techniques to each
specific field.
Applications in ophthalmology were most

DIRECTOR
MULTI-DISCIPLINARY INTENSIVE
CARE UNIT
The Hospital

The Calgary General Hospital is a modern 928-bed
active treatment hospital. It is affiliated with The
University of Calgary, and conducts graduate and
under graduate training programs in all clinical
departments.
The Position

This w ill be a fu ll tim e appointment and the Director
would be responsible for overall direction of the
unit; consultations to the Medical Staff; education
of physicians, residents and para medical personnel;
and various administrative duties.
The Candidate

The successful candidate w ill be a certified spe
cialist in internal medicine, surgery or anesthe
siology, or one of the sub specialties thereof, and
w ill be eligible for licensure in Alberta. Experience
in critical care medicine is essential, and the candi
date should also have abilities in development of
patient care programs, teaching and administration.
Please apply by sending a complete curriculum vitae to:
M r. A. J. Maiani
Associate Executive Director
CALGARY GENERAL HOSPITAL
841 Centre Avenue East
Calgary, Alberta T2E 0A1
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